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Chapter I 
GENERAL INTRODUCTION 
The influence of systemic and intrauterine infections in pregnant women on the 
course and outcome of pregnancy has been extensively investigated. There is good 
evidence that infection during pregnancy can be associated with abortion25 ,134,143, 
stillbirth55,57, pretenn rupture of membranes (PROM)132,J38, preterm labor and 
delivery l29 and low birthweight17·I40.I46. Many studies focus on the effects of gram 
negative bacteremia in clinically manifest or subclinical decidual-amniochorionic 
infections and the role of endotoxins or endotoxin-induced mediators in the etiology of 
PROM and the induction and maintenance of preterm labor and delivery59,11O.130, 
Endotoxins, cell wall antigens of gram negative bacteria, have been widely 
studied in connection with the diversity of biological respcnses elicited by these 
macromolecules in vivo and in vitro; they proved to be major factors contributing to the 
pathophysiologic mechanisms involved in gram-negative bacteremia and septic 
shockl".I". They have been characterized as Iipcpclysaccharides (LPS) and identified 
and immunochcmically analyzed with respect to gram-negative bacteria, especially the 
aerobic Elllero/Jacteriaceae. Recent research has revealed that endotoxic 
Iipopolysaccharides are capable to elicit in the host the release of a variety of host 
effector molecules, including inflammatory mediators and imlllunoregulatory 
cytokines"·5o. This capacity of lipcpclysaccharides appears to be respcnsible for the 
pathophysiologic mechanisms involved in gram-negative sepsisS,4S,68. 
The bacterial flora involved in intrauterine infections is complex, with a 
prevalence of Escherichia coli and Bacteroides species of the gram negative group41.60. 
Most experimental studies of the influence of bacteria or endotoxins on the development 
of complications of pregnancy were performed with the aerobic E.coli. The anaerobic 
Bacteroides species, the most commonly isolated anaerobic bacteria in obstetric and 
gynecologic infections", have been investigated less frequently. It is claimed that 
lipopclysaccharides isolated from Bacteroides species exhibit only weak biological 
activHylOl,142, but it was demonstrated that B.fragilis is involved in abortion, 
stillbirth lll ,l4J and PROM'!. I" , and that B.jragilis and B.bivills are associated with the 
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development of preterm labor and birth in subclinical and clinically manifest 
infections9J ,94,lIJ,1l2, Culture supernatants of B.fragilis have been shown to stimulate the 
release of prostaglandin ~, known to stimulate uterine contractions, from amnion 
cells I2 ,97. 
The significance of gram negative bacteria and endotoxins as a risk factor of 
abnormal fetal growth has been investigated only occasionally. Subclinical decidual-
amniochorionic infections were shown to be associated with fetal loss and impaired or 
retarded fetal development"··J7; a few clinical studies have revealed a correlation 
between the presence of gram negative aerobes (Escherichia coli, Chlamydia) or 
anaerobes (Bacleroides species) in the amniotic cavity and low birthweight"·JJ2.J46. In a 
large multicenter study among a cohort of 13.914 pregnant women Germain et a1." 
showed that the presence of anaerobic gram-negative rods of the genera Bacteroides, 
Prevotella and Porphyromonas in the vaginal and cervical flora of pregnant women 
during the second trimester of pregnancy was significantly associated with an increased 
relative risk of fetal growth retardation. For studies dealing with the influence of 
infections on birthweight corrected for gestational age an exact dating of the pregnancy 
is mandatory, but many of the clinical studies do not differentiate between low 
birth weight because of prematurity and because of fetal growth retardation ("small-for-
gestational age" neonates). Animal models permit exact dating of the gestation, and the 
effects of infections with Campy/obae/er IJ7, Escherichia coli and Bacteroides bivius"2 
and of endotoxins isolated from E.coli, Sallllollella ryp/lillllll'iul/I, Shigella dysellfel'iae 
and Vibrio eho/eme on fetal growth were investigated in such models53 . 12 ],125,128.167. 
Sublethal doses of bacteria or endotoxins were administered intravenously, 
intraperitoneally or subcutaneously in mice and rabbits, in an attempt to mimick 
bacterial infection; and abortion and impaired fetal growth were observed repeatedly, 
but fetal growth retardation at the end of gestation was reported in only few studies"·30. 
This thesis presents the results of experimeutal studies in the preguant guinea pig 
designed to evaluate the effects of B.jragilis endotoxin on fetal growth and to explore 
the physiologic and pathologic reactions in the host. 
The pregnant guinea pig was chosen as an experimental model because of the similarity 
of the guinea pig and human placenta, which are both hemochorial. Moreover, the 
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length of gestation in the pregnant guinea pig, ca. 65 days, allows the development of a 
sufficiently high anti-endotoxin antibody response before delivery. 
The following questions were specifically addressed: 
Does B.fragilis endotoxin elicit a specific immune response in the 
pregnant guinea pig and the fetus? 
What is the impact of B.fragilis endotoxin on fetal growth? 
Is there an effect of B.fragilis endotoxin on maternal and fetal 
metabolism? 
Does B.fragilis endotoxin stimulate the release of inflammatory mediators 
in the pregnant animal? 
Is it possible to describe basic struclural fealures in B.fragilis endotoxin 
that might explain the biological activity of this lipopolysaccharide in vivo 
and in vitro during pregnancy? 
The answers to these specific questions will be presented and discussed in 
chapters 2-7. 
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Chapter 2 
IMMUNE RESPONSE TO BACTEROIDES FRAGILIS ENDOTOXIN 
IN THE PREGNANT GUINEA PIG* 
2.1. Introduction 
The gram-negative Bacteroides species are frequently involved in intrauterine 
infections, often in association with other microorganisms40,60,78.129, Though Bacteroides 
species have been isolated from amniotic fluid in cases of clinically manifest infections, 
little is known about the specific immune response to these bacteria in apparently 
healthy and clinically infected pregnant women and their fetuses. Gibbs et al .. " 
measured Immunglobulin G (IgG) against B.hivius in serum and amniotic nuid from 
healthy pregnant women and from pregnant patients with clinical intraamniotic 
infections, with and without B.bivius contamination in the amniotic fluid. They found 
significantly higher antibody titers in patients with intraamniotic infection in which 
B.hivius was cultivated from amniotic fluid than in women with clinical symptoms of 
infection but negative amniotic fluid cultures, and in healthy controls. Evaldson et aL 42 
found specific IgG against B.fragilis in 14 sera and 12 amniotic fluid samples obtained 
from 30 pregnant women without signs of infection. No correlation was observed 
between the levels of antibody titers in serum and those in amniotic fluid. There are 
several studies indicating impaired cell-mediated immunity during pregnancy69 ,160; the 
innuence of pregnancy on the humoral immune response is not yet fully explored and 
seems to depend on the nature of the antigen and the species of the host. 
This chapter presents the resuits of an experimental study in the pregnant guinea 
pig, designed to evaluate the immune response to B.fragilis endotoxin in mother and 
fetus, and to compare it with the response in the nonpregnant animal. 
* The main slIbstance of this chapter was pllblished in; BeckmaIJII 1, Meisel-MikQlnjczyk F, 
Leszczynski P, Wallenbllrg HeS. 111/ Arch Allergy App/lI11I11I/1W/ 1990;93;222-226. 9 
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2.2. Material and Methods 
2.2.1. Erfractioll and isolation of l'lIdOla.rill 
BJragi/is IPL E 323 culture collection reference strain was cultivated in yeast-
broth medium l62 at 37"C for 48 hs. The culture was centrifuged at 1500 g and the 
deposit collected. The bacterial bulk was extracted with aqueous phenol according to 
Westphal et al. l63 • The water phase was dialyzed against tap water and distilled water, 
filtered through a Schott G 5 filter, concentrated and Iyophylized. The resulting 
substance, the crude endotoxin, was dissolved in phosphate-buffered saline (PBS) pH 
7.4. The solution was boiled for three min and used for immunization procedures and 
serological tests. 
2.2.2. Animals 
All animals were of the same batch of virgin albino Dunkin-Hartley guinea pigs 
and bred in our laboratory facilities. The guinea pigs were kept in individual cages in a 
controlled environment (19", 50 % humidity, light-dark circle 13111 h), and were fed 
commercial guinea pig pellets, hay, and water ad libitum. The total food intake was 
carefully recorded. Vitamin C was added to the drinking water twice weekly. In 
pregnant animals, the first day Of gestation was defined as the second day of the 
opening of the vaginal membraneJ5 . Five healthy pregnant animals were used for the 
sampling of control blood and amniotic fluid. 
2.2.3. Immunization (?f guinea pigs 
a. Imra11l1lscular with fOn1wlinized bacteria. Five nonpregnant virgin guinea pigs 
(median weight 543 (527-593) g) were immunized with a vaccine of formalin-killed 
B.fragilis IPL E 323 bacteria suspended in saline in a concentration of 2xlO I0 c.f.u.lml. 
Two injections of 0.25 ml vaccine diluted I: I with complete Freund's adjuvant each 
were given into the right and left hind limb on day O. A booster injection of 0.25 ml 
vaccine diluted I: I with incomplete Freund's adjuvant was given on day 30. The final 
titer was determined on day 49. 
2. III/ramliscillar with B.jragilis IPL E 323 elldO/oxill. Five nonpregnant virgin 
guinea pigs (median weight 543 (527 - 593) g) and 12 pregnant guinea pigs (median 
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weight on gestational day 30 803 (701-928) g) were immunized with B.fragilis IPL E 
323 crude endotoxin dissolved in PBS pH 7.4. For the first two injection schedules the 
crude endotoxin was dissolved in 0.1 ml PBS and for the subsequent injections in 0.2 
ml PBS. The endotoxin solutions were emulsified in equal volumes of either complete 
or incomplete Freund's adjuvant (Sigma, St.Louis, U.S.A.), and injected 
intramuscularly into one or both hind limbs. The following scheme of immunization was 
applied: day 0 (in pregnant animals day 30 of pregnancy): 100 )1.g endotoxin/kg body 
weight (bw); day 6: 200 )1.g endotoxin/kg bw; day 12: 400 )1.g endotoxin/kg bw; day 18: 
800 )1.g endotoxin/kg bw; day 24: 1000)1.g endotoxin/kg bw. Preliminary investigations 
revealed that complete Freund's adjuvant should be used in order to reach sufficiently 
high antibody titers during immunization with B.fragilis endotoxin. Accordingly, 
complete Freund's adjuvant was used for the tirst immunization, whereas all booster 
injections were given with incomplete Freund's adjuvant. The final titer was determined 
on day 31/32 (day 61/62 of pregnancy). 
2.2.4. Sampling qf malel'lla/ ant! felal bloot! ant! amniolic jlait! 
After completion of the immunization scheme (for pregnant guinea pigs~oJl day 
61 of pregnancy), the animals were ancSlhetised with an intramuscular injection of 
ketamin-hydrochloride (15 mg/kg bw) and xylazine-hydrochloride (2 mg/kg bw). The 
nonpregnant and pregnant animals were weighed and bled by heart puncture. In the 
pregnant animals, the abdomen was opened, and amniotic fluid samples were withdrawn 
from the amniotic cavities. The fetuses were then removed and weighed. Blood was 
taken from the fetuses by heart puncture. 
The blood samples were kept at 37"C for 30 min until clotting was complete. 
The amniotic fluid and blood samples were then centrifuged at 4"C and 1500 g for 10 
min, and the amniotic fluid supernatants and the sera were stored at -20()e until 
analysis. 
2.2.5. Reference sera 
Reference sera against B.fragilis IPL E 323 bacteria were prepared in rabbits as 
described by Meisel-Mikolajczyk and PtlczynskaJ07 • The hemagglutination titers against 
B . .fragilis endotoxin were I: 1280 - 1 :2560. 
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2.2.6. lnaclivalion q( igM iIIllibot/ie,\" wilh t/ilhiolilreiloi 
According to Olson et al '18 , equal volumes of a 0.01 M solution of dithiothreitol 
(Sigma, St.Louis, Mo.,USA) in PBS pH 7.4 and antiserum diluted 1:5 in PBS were 
incubated at 37"C for 30 min. Controls containing equal parts of PBS and 1:5 diluted 
antiserum were incubated simultaneously. After incubation, inactivated sera and controls 
were titrated in hemagglutination tests. 
2.2. 7. Serological lesls 
a. Hemaggllllination lesls. Hemagglutination tests were performed on microtiter 
plates as described previously", with endotoxin-coated formalinized sheep erythrocytes 
as antigens. 
b. Passh'e hemolysis fest. These tests were performed according to the method of 
Kontrohr and Peterffy". Fresh sheep erythrocytes coated with B.fragilis IPL E 323 
endotoxin were used as antigens; normal guinea pig serum, absorbed with uncoated 
sheep erythrocytes, served as the source of complement. After inactivation of 
complement by incubation at 56°C for 30 min, the hemolytic activity of the guinea pig 
sera was determined spectrophotometrically at 413 nm; the final serum titer was defined 
as 25 % hemolysis. 
c. Coombs lesl. The indirect Coombs test was performed according to the 
modifications of Wagner and Kuhns l56 with commercial rabbit immunoglobulin against 
guinea pig immunoglobulins (Dakopatts, Glostrup, Denmark) as second antibody. 
A serum concentration of two dilutions (I :2) below the final hemagglutination 
titer was chosen as the baseline antiserum dilution. This solution was than further 
diluted (1 :2) in PBS (pH 7.4) and 100 1'1 of each serum dilution were incubated with 
100 1'1 of a 1 % formalinized sheep erythrocyte suspension, coated with endotoxin 
B.fragilis IPL E 323. After incubation at 37"C for 3 hs, the erythrocytes were 
centrifuged at 1500 g for 10 min, washed three times with PBS and resuspended in 100 
1'1 PBS. Rabbit anti-guinea pig 19 immuno-globulin was diluted 1: 100 in PBS (pH 7.4) 
and 25 1'1 of this solntion were added to 251'1 erythrocyte suspensions in microtiter 
plates. The results were read after 3 hs at 37"C and overnight incubation at 4°C. 
d. Crossed immunoelectrophoresis. First-dimension (Grabar) immuno-
electrophoresis of the endotoxin (2 mg/ml PBS, pH 7.4) was performed as described 
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previouslyll in agarose gel (I % agarose in Laurell buffer pH 8.4 159) on microscope 
slides at 3 V/cm for 150 min. Second-dimension electrophoresis of the separated 
antigenic fractions into reference serum was carried out on 5x5 em glass plates at a 
field strength of 5 V Icm for 6 hs at lO°e. The reference serum was a rabbit antiserum 
against formalin-killed bacteria B.ji'agilis IPL E 323, with either PBS or guinea pig 
immune serum in the intermediate gel. After washing with PBS and drying, the 
precipitates were stained with Coomassie Brilliant Blue G 250 according to Weekel59 . 
2.2.8. Slatislical evailialioll 
The Wilcoxon rank-sum test was used to analyze differences in fetal weight 
between the group of pregnant guinea pigs immunized with B.fragilis crude endotoxin, 
and nonimmunized pregnant control animals. A value of p < 0.05 was taken to 
represent statistical signitlcance. 
2.3. Results 
At no time throughout the period of endotoxin - or placebo - administration any 
serious maternal illness was noted. A ruffled coat was observed in most endotoxin-
treated animals and disappeared two days after endotoxin-injections. 
2.3.1. Alllibodies ill !/ol/pregllalll guillca pigs ({{ler immunization with jonnaline-killed 
B.ji'agilis baeleria alld lVilil (,lId%xill [rom B./iYlgilis. 
The antibody titer against B.fragilis endotoxin before immunization was < 1: 10 
in all animals. Data on the response to intramuscular immunization with killed bacteria 
and extracted endotoxin are presented in table 2.1. 
No differences were apparent between the antibody response of sera obtained 
after immunization with killed bacteria and the extracted crude endotoxin. Immunization 
with killed bactera as well as crude endotoxin elicited IgM, IgG and "Coombs" 
incomplete antibodies with a slightly higher rate of IgM and lower content of 
complement-fixing and incomplete antibodies in sera obtained by immunization with the 
endotoxin. 
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Table 2.1. 
Imnunization 
with 
formal in-
killed 
bacteria 
endotoxin 
Serological response to intramuscular imnunization with B.jhlgilis iPL E 323 endotoxin 
and formal in-ki lied bacteria in individual nonpregnant guinea pigs 
Titers 
hemag9lut i nat i on h~tysis Coombs 
1: 160/160 1:160 1: 5120 
1 :320/320 1:160 1: 5120 
1:640/160 1 :320 , :102liO 
1:160/80 1: 80 1, 5120 
1 :320/ liO 
" 
10 1: 5120 
1: 640/ 80 1: 80 1: 5120 
I: 1280/160 1: liD 1: 5120 
1: 320/ 80 1: 80 1: 5120 
" 
160/ liO 1: 80 1: 2560 
1: 3201 liD 1: liD t: 2560 
total antibody titer/dithiothreitol-resistent titer 
sampling of guinea pig blood after irrmunization with bacteria on day 49, after inmunization with crude 
endotoxin on day 31 after the first endotoxin injection. 
The crossed immuno-electrophoresis (CIE) - pictures (figure 2.1. b,c) show that 
endotoxin as the immunizing agent produces the same antibody spectrum as full 
bacteria. Figure 2.1. also shows that antibody fractions reacting with B.jragilis 
endotoxin are the same in rabbit reference serum against bacteria as in guinea pig sera 
against bacteria or endotoxin (Fig.2.1. a,b,c). 
2.3.2. Allfiboi/ies in nonpregnllllf and pregnallf guinNI pigs tifter immunization with 
B.jragilis eni/olOxin 
Intramuscular immunization with B.fragilis endotoxin was performed in 5 
nonpregnant and 12 pregnant guinea pigs. The antibody titer against the endotoxin 
before immunization was < 1:10 in all animals. For pregnant guinea pigs, the 
immunization started on day 30 of gestation. One animal aborted and died after the fifth 
immunization on day 55; in 11 animals, the immunization scheme was completed. 
The immune response to B.fragilis endotoxin in nonpregnant and pregnant 
guinea pigs was compared by means of passive hemagglutination (IgG and IgM), 
passive hemagglutination after inactivation of IgM by dithiothreitol (IgG), passive 
hemolysis (complement-fixing antibodies IgG,), and Coombs test (incomplete 
antibodies). The results are presented in table 2.2. 
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Figure 2.1, a,b,c: Crossed imllllllloeieclJ"Ophoresis (e/E) wilh elldotoxin isolated from B.fragilis IPL E 323 
and rabbit alltiserum agl/im' B./ragilis 
0) CIE of endotoxin E 323 with blank illfel1l1ediate gel 
b) CIE of ('1It/otoxin E 323 lI'ith guinea pig (nonpregnallt) onliserum against bacteria E 323 ill the 
illferll/cdlale gel 
c) CIE of elldotoxin E 323 wilh guinea pig (nonpregnant) allfiserllll1 against E 323 endotoxin ill the 
illlermediate gel 
15 I1g endoloxin, separated i1l the first dbm'llsioll electrophoresis, was Hill ill the secolld dhllellSioll 
againsl 100 pi rabbit allfiscntlll (bacteria) ill J 700 pi agorose. illfermediafe gels (6fXJ pi agarose) 
cOlltailled ill a) 60 pi PBS, ill b) 60 jJ/ guillea pig (1/ollpregllollf) (lnlisemm (bacteria), ill c) 60 J11 guillea 
pig (nonpregnant) alltisen/III (ent/otoxin). 111e cathodic gel (300 pI) colltaillcd ill a) 35 pi rabbit 
allfise1'llm, ill b) 35 111 gllillm pig alltiserum (bacteria) alld c) 3511/ guinea pig allliserum (elldotoxill). 
17 
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Table 2.2. Antibody response to intramuscular inm;nization with B.fragilis IPL E 323 t!ndotoxin in nonpregnant 
and pregnant guinea pigs 
Nonpresnant sui nea pi gs. PrC9nant guinea pigs. 
~. Titers No. ~ 
. . 
hemaqglutination hemolysis ~ hemagglutinati on hemolysis 
1: 640[ 80 1 :80 1:5120 6 1: 1280[320 1:160 
2 1 :1280[160 1 :40 1 :5120 7 1: 640/160 1: 80 
3 1: 320[ 80 1:80 1:5120 8 1: 160[ 40 1: 40 
4 1: 160[ 40 1:80 1:2560 9 1: 640[ 80 1: 80 
5 1: 320[ 40 1:40 1:2560 10 1 :1280[ 80 1: 40 
Total antibody titer [ dithiothreitol-resistant titer 
Sarq:.ling of guinea pig blood on day 31 after the first endotoxin-irdection 
COom'" 
1 :5120 
1 :5120 
1: 640 
1 :5120 
1:5120 
Precipitating antibodies in guinea pig immune sera obtained from nonpregnant 
and pregnant guinea pigs were investigated in crossed immunoelectrophoresis (CIE) as 
shown in Figure 2.2.(a,b). 
- t---- + - t---- + 
1 1 
II b 
Figure 2.2. a,b.: eros.H'd iml1lf1l1veil'Ctrophol"l'sis (CIE) with crudl' me/atox;n isolated from B.fragilis IPL 
E 323 alld rabbit allf;.\"erllm agaillsl B.fragilis 
a) CIE of crude endotoxin E 323 with guinea pig (nol/pregnant) antiserum against E 323 crude 
endotoxin ill the illfermediate gel 
b) CIE of crude endotoxin E 323 It'illl guinea pig (pregnant) allfiserlllJl against E 323 crude 
endotoxin ill fhe iJltl'l"lllediate gel 
15 pg elldotoxin, separated ill the first dimension eh'c/rophoresis, was rtm iI/ the second dimellsioll 
against TOO pi rabbit alltiserum (bacteria) ill 1700 pi agarose. Intermediate gels (600 pi agarose) 
contailled 
;n a) 60 pi glliuea pig (llollpregnalll) antiserum (elldotoxin), 
ill b) 60 pi guinea pig (pregnallt) alltisentlll (endotoxin). 
The cathodic gel (300 Il/) col/laincd;/l a and b 35 111 guinea pig nllliserum (crude endotoxin) 
No differences in hemagglutinating -, complement fixing - and incomplete antibodies or 
the IgG \ IgM ratio were observed between nonpregnant and pregnant guinea pigs. The 
CIE picture obtained with serum from endotoxin-immunized pregnant guinea pigs 
revealed the same antibodies at similar concentrations as present in serum from 
nonpregnant animals after immunization with crude endotoxin. 
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2.3.3. Al1Iihodies against B.fragilis elldotoxin in maternal 0/1(/ /'-'tal .\·era 0/1(/ amniotic 
fluids of pregnalll guinea pigs. 
The antibody response to B.fragilis endotoxin in 11 pregnant animals as 
determined in maternal and fetal sera and amniotic fluids is shown in table 2.3. 
Maternal and fetal sera and corresponding amniotic fluids of 5 nonirnmunized 
pregnant guinea pigs were run with the tests as controls. No antibodies against 
endotoxin were detected in these sera and amniotic fluids (titers < 1:2 for fetal sera 
and amniotic fluids). The examination of fetal sera for anti-endotoxin antibodies, before 
and after treatment with dithiothreitol, revealed IgG and IgM in lower titers than in the 
corresponding maternal sera as well as a higher percentage of incomplete antibodies. 
Antibodies against B..fragilis endotoxin were detected in low titers in 10 out of II 
amniotic fluids. These antibodies were partially inactivated by dithiothreitol. The data 
are summarized in table 2.3. 
2.3.4. The effect of immunization with B.fragilis (,Ildotoxin all /l-'tal weight. 
The median fetal weight per litter in 8 immunized animals (with 3 or 4 fetuses 
per litter) was 10 g less than that in a control group of 8 nonimmunized guinea pigs on 
day 61/62 of gestation (p<0.05), randomly chosen from a large group of healthy 
pregnant guinea pigs with uncomplicated pregnancies bred in our laboratory. 
2.4. Discussion 
The main aim of our study was to determine to what extent pregnancy affects the 
immune response potential of guinea pigs following immunization with B.fragilis 
endotoxin, and whether such immunization induces the formation of antibodies in the 
fetus and in amniotic fluid. The pregnant guinea pig was chosen as the experimental 
animal model to assess the impacts of B.jragilis endotoxin on mother and fetus during 
pregnancy. The choice of the guinea pig was based on the structural similarity of the 
glIinea pig and human placenta, which are both hemochorial. Moreover, the length of 
gestation (ca. 65 days) allows the development of sufficiently high anti-endotoxin 
antibody titers before delivery. 
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TabLe 2.3. HemaggLutination titers in maternal and fetal sera and in allTliotic fluid isoLated from pregnant guinea pigs 
after illlllUl'l1z:ation OIit:h S.fragitis I?L E 323 endotoxin 
Guinea pig 
no. 
6 
7 
8 
9 
10 
" 
12 
13 
14 
15 
16 
Titers in matemal serun 
. 
hemagg( uti nat; on Co""",, 
1 :1280/320 1: 5120 
1: 6401160 1: 5120 
1: 1601 40 
" 
640 
1: 6401 80 1: 5120 
1:12801 80 1: 5120 
1: 6401 40 1: 2560 
1: 320/320 1: 2560 
1: 640/40 1: 5120 
1: 640/640 1:10240 
1: 320/160 1: 5120 
1: 6401160 1: 5120 
: TotaL antibody titer / dit:hiot:hreitoL-resistant titer 
Titers in fetaL sen£! 
. 
hemaaslutination ~ 
1 :2561 32 1 :2560 
1:128/64 1 :1280 
1: 161 8 1: 320 
1:128/128 1:2560 
1: 16/ '- 1: 640 
1: 32/ 16 ,: 320 
1: 16/ 8 1: 320 
1: 64/64 1:1280 
1 :128/128 1:2560 
1:1281 32 1 :2560 
1:128/ 16 1:1280 
~ljng of guinea pig bLood and allJ'liot:ic fLuid on day 31 after the first endotoxin-injection 
Titers in armiotic fluid 
. 
hernaqq l uti nat; on 
1: 8/2 
1: 8/2 
" 
<2 
1: 8/8 
" 
4 
1:1612 
1:8/<2 
" 
2 
1, 2 
1:8/<2 
1:8/<2 
Crude B.fragilis endotoxin was used as the immunogen because this cell wall constituent 
carries biological activity' and presents an important component of the immunogenic 
complex of these bacteria. B.fragilis LPS is immunogenic in mice'''. CIE with the 
crude endotoxin as antigen showed that all components of this preparation were 
immunogenic in guinea pigs. Whereas polysaccharides are nonimmullogenic in guinea 
pigs, immunogenicity of LPS in guinea pigs has already been described48.". Guinea pig 
antisera against endotoxin isolated from B.fragilis reacted with similar titers as sera 
against bacteria, but the proportion of incomplete antibodies was lower and the 
percentage of IgM was slightly higher. The OCCurrence of IgM in the immune response 
could be expected since B.fragilis is known to induce IgM-synthesis in LPS-responsive 
mice149,157. 
The endotoxin was administered intramuscularly, which might lead to a slower uptake 
of the LPS into the maternal circulation than achieved by the usual intravenous or intra-
peritoneal route. The intramuscular route was chosen to mimick chronic infection. 
Various studies have indicated that pregnancy may be associated with a certain degree 
of immune suppression69,160, However, no significant reduction in the immune 
responsiveness to B.fragilis endotoxin was detected in pregnant guinea pigs as compared 
with that in nonpregnant animals. It should be noted that both the pregnant and 
nonpregnant animals were immunized using the same schedule, with the incorporation 
of endotoxin in Freund's adjuvant. The antibody response as measured by IgG and IgM 
serum antibodies and as demonstrated in CIE and Coomb's test in pregnant animals is 
similar to that observed in nonpregnant animals, which is in agreement with previously 
reported data on the antibody response to lipopolysaccharide in pregnant mice'. 
Of interest is the finding that IgM-type antibodies to B.fragilis endotoxin were 
present in fetal sera. The source of the IgM type antibodies in fetal serUill is not clear. 
In rabbits, rats20,21,96 and guinea pigs4.21 antibodies are transferred from mother to fetus 
via the yolk sac splanchnopleur and vitelline vessels, and not across the placenta. The 
yolk sac splanchnopleur in rabbits does not select for the transmission of different types 
of y-globulins, including IgG and IgM21 •67.'''. Transfer of IgM across the yolk sac in 
guinea pigs would explain our finding of IgM antibodies of the anti-endotoxin type in 
the amniotic fluid. Another possibility is that the transfer of endotoxin antigen from 
mother to fetus could induce the formation of IgM type antibodies in the fetal IgM 
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immunoglobulin fraction. The development of the fetal immune system in guinea pigs 
reaches immunocompetence about gestational day 35 124 ,145; transferred endotoxic LPS 
could thus induce fetal anti-LPS antibodies. A few experiments, described in chapter 7, 
were performed to assess the transfer of B.fragilis endotoxin into the fetal compartment. 
The endotoxin was detected in amniotic fluid of two endotoxin-immunized guinea pigs, 
This finding indicates that the detected fetal anti-endotoxin IgM antibodies could indeed 
be of fetal origin. 
The main visible impact of B.fragilis endotoxin on the pregnant guinea pig after 
repeated administration during the second half of gestation was a significant reduction in 
fetal weight. Chapter 3 will deal with the question whether or not the reduction in fetal 
weight is due to the endotoxin itself or to the stress of the immunization procedure, 
including the use of Freund's adjuvant. 
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Chapter 3 
THE IMPACT OF BACTEROIDES FRAGILIS ENDOTOXIN 
ON MATERNAL AND FETAL GROWTII* 
3.1. Introduction 
The effects of endotoxins from gram negative bacteria on course and outcome of 
pregnancies have been recognized since many years. Injection of sublethal doses of 
endotoxin into animals has been reported to cause fetal resorption. abortion and still-
birth29,JO,S5.J25,167. It is also known from clinical studies in women and experiments in 
animals, that subclinical or mild bacterial infections during pregnancy are frequently 
associated with impaired fetal developementJ2.58.1 17.143 I prematurity59,1l2,129 and retarded 
fetal growthJO,56,8).1l2,1-l6. Reported studies in animals were almost exclusively performed 
in mice or rabbits; injected gram negative bacteria or endotoxins were the aerobic 
E.coli, Sa/monel/a species, Shigella, Vibrio cho/erae or Campy/obacler, and anaerobic 
Bacteroides species. 
In the study of the immune response in pregnant guinea pigs to B.fragilis endotoxin as 
reported in chapter 2, a markedly reduced fetal weight was observed in endotoxin-
treated animals. On the basis of the previous experiments it could not be excluded that 
the stress of the immunization procedure. including the use of Freund's complete 
adjuvant, could have had a negative influence on fetal growth. 
For that reason, the present study was designed to test the hypothesis that the endotoxin 
is responsible for the reduction of fetal weight in endotoxin-treated pregnant guinea 
pigs, and to assess effects of endotoxin on the development of fetal and maternal weight 
during pregnancy. 
* I1w main substallce of this chapter was published ill " Beckmallll I, Meisel~Mikaf(ljczyk F, 
Le,sZCZYIISki P, Brooijmolls M, Walll'lIburg HCS, Am J Obsfef Gynecot 1993; 168: 714-8,8 
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3.2. Material and Methods 
3.2.1. Extraction, isolation and purification of endotoxin 
The extraction and isolation of B.fragilis IPL E 323 crude endotoxin are 
described in chapter 2.2.1., the purification of B.fragilis endotoxin is described in 
chapter 6. 
3.2.2. Animals 
Experiments were performed between days 30 and 61 of gestation in 18 albino 
Dunkin-Hartley guinea pigs bred in our laboratory facility. The first day of gestation 
was defined as the second day of the opening of the vaginal membrane. The conditions 
of animal care are described in chapter 2.2.2. The total intake of food was carefully 
recorded. 
3.2.3. Endotoxin administration 
Nine randomly selected animals were injected with a solution of purified 
B.fragilis IPL E 323 endotoxin, dissolved in phosphate-buffered saline (PBS) at pH 7.4, 
diluted I: I with Freund's adjuvant (endotoxin group I). The other nine animals received 
injections with the solvent only (sham-group). The same scheme of intramuscular 
injection used in the study described in chapter 2.2.3. was applied. Complete Freund's 
adjuvant was used for the first injection, all following injections were with incomplete 
Freund's adjuvant. The nine sham-treated guinea pigs received PBS with complete 
Freund's adjuvant in the first and incomplete adjuvant in the following injections, 
according to the scheme followed for the endotoxin-treated animals. 
For the evaluation of the impact of B.fragilis endotoxin on the course of 
maternal and fetal weight unpublished data on maternal and fetal weight obtained during 
the immunization studies with crude endotoxin as reported in chapter 2 were used to 
compose a third study group of nine endotoxin-treated pregnant guinea pigs (endotoxin 
group II). 
3.2.4. Experimelllal protocol 
Starting on day 28 of pregnancy, the animals were weighed every other day. 
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Blood was collected on day 30 (maternal) and day 61 (maternal and fetal) by heart 
puncture under anesthesia obtained with an intramuscular injection of ketamine 
hydrochloride (15 mg/kg body weight) and xylazine hydrochloride (2 mg/kg bw). The 
blood samples were kept at 37°C for 30 min until complete clotting. The amniotic fluid 
and blood samples were then centrifuged at 4"C and 1500 g for 10 min, and the 
amniotic fluid supernatants and sera were stored at -20°C until analysis. 
On day 61 the abdomen was opened under anesthesia, amniotic fluid was sampled, the 
fetuses and placentas were removed and weighed. In five animals of the endotoxin and 
sham groups the maternal and fetal livers were removed and weighed. 
Antibody titers against B.fragilis endotoxin were determined in all blood samples 
by means of hemagglutination tests on microtiter plates as described in chapter 2.2.7. 
3.2.5. Statistical alia lysis 
Data are presented as median (range) throughout. Wilcoxon's rank-sum and 
rank-sign tests were used to evaluate differences between measured variables. A value 
of p < 0.05 was chosen to represent significance. 
3.3. Results 
Before the start of the experiment on day 30 of gestation, hemagglutination titers 
against B.fragilis endotoxin were < 1:10 in all animals. The nine endotoxin-treated 
guinea pigs in the study groups I and II responded with a median hemagglutination titer 
of 1 :320 (range 1 :40 to 1:640). 
At no time throughout the period of endotoxin - or placebo - administration any 
serious maternal illness was noted. A ruffled coat was observed in most endotoxin-
treated animals and it disappeared two days after endotoxin-injections. 
3.3.1. Maternal weight 
Maternal weight at the beginning of the experiments on day 30 of gestation was 
not different between the three groups (Table 3.1.). Total maternal weight gain between 
gestational days 30 and 61 was slightly different between the two endotoxin-groups and 
the sham-group: maternal weight gain in endotoxin-group I (31 %) was similar to that 
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in sham-treated controls (36 %), but that in endotoxin-group II (24 %) was significantly 
lower. When standardized for litter size, the median increase in maternal weight in the 
two endotoxin-treated groups was 14 %, and 25 % respectively, less than in the sham-
treated group (p < 0.05). No difference in food intake between groups was observed. 
A characteristic example of the course of maternal weight in both groups is shown in 
figure 3.1. 
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3.3.2. Fetal weight 
Two of the 70 fetuses in the endotoxin-groups were stillborn, a nonsignificant 
difference with one of 32 in the sham-treated animals. One guinea pig which aborted 
three fetuses after the fifth endotoxin-administration was not included in the two 
endotoxin-groups. Obvious impaired fetal growth with one to three partly resorbed 
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fetuses in the uterine horn was observed during dissection in three endotoxin-injected 
guinea pigs; this was not observed in sham-treated animals. None of the fetuses 
displayed gross abnormalities. 
The total number of fetuses, the number of fetuses per litter, and fetal weights in the 
three groups are also presented in table 3.1. The number of fetuses per litter was not 
different between the endotoxin-treated animals and sham-treated controls, but median 
fetal weight in the endotoxin-treated groups was lower by 12 - 19 % than that in 
controls (p<O.OOI). 
3.3.3. Placelllal weighl alit! weighl qf III" fdal liver 
No innuence of endotoxin - treatment was observed on placental weight and 
placental weight per litter (Table 3.2.). However, table 3.2. shows that the median 
weight of the fetal liver in the endotoxin-treated animals was 37 % lower than that in 
sham-treated controls (p<O.OOOI). 
3.4. Discussion 
Intramuscular administration of B.fragilis endotoxin in the second half of 
gestation appears to calise a significant reduction in fetal weight. The experimental 
design of the study, with controls receiving identical treatment except for the use of 
endotoxin, excludes a significant effect of stress from the immunization procedure and 
from the use of Freund's adjuvant. 
It is of interest that placental weight is not affected by endotoxin-treatment. That 
makes it nnlikely that the reduction in fetal weight is caused by a reduced uteroplacental 
supply of nutrients and gases, which would also have affected placental weight. The 
marked reduction in fetal liver mass in endotoxin-injected guinea pigs indicates that not 
only fat deposits are reduced but that the endotoxin challenge disturbs fetal metabolism. 
It is known that endotoxins may interfere with carbohydrate and fat metabolism I4,106.139. 
Endotoxins from gram negative aerobes have been shown to influence fetal 
developement in mice by causing fetal resorption and abortion29 . .'i.'i.12.'i.128,167. 
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TabLe 3.1. The deveLop:nent of maternaL and fetaL Ioleigh't in endotoxin-'treated ard sham-treated guinea pigs. 
p. Endo'toxin-group I Sham-group Endotoxin-group II 
,. 
(n=9) (n=92 (n--9) 
MaternaL Ioleight (g) NS 828 (788-880) 827 (677-930) 824 (738-928) NS 
at 30 days' ges'tation"', 
Ma'ternal Ioleight g3in NS 286 (106-347) 301 (235-480) 199 (102-3'7) p < 0.05 
days 30-61 (g)"', 
Maternal Ioleigh't gain p < 0.05 n ( 39- 87) 84 ( 72-123) 63 ( 34- 79) P < 0.0' 
per fe'tus (g''*", 
Fetuses (total nUTber) NS 35.2 32"3 3S NS 
W Fetuses per liner"", (m,mber) NS 4 ( 2- 5)·2 4 ( 2- 6) .... 3 3 ( 2- 5) NS 0 
FetaL Ioleight (g) .... , p < 0.05 76.6 <45.5-95.4)"'4 84.9 (75.3-97.3) .... 4 65.3 (52_5-75.6) p < 0.01 
per Liner 
Fetal Ioleigh't (g)*, p < 0.001 73.0 (39.'-95.4) .... 4 83.3 (63.6-'03.5) .... 4 67.0 (44.7-84.7) P < 0.00' 
.... , resuL'ts expressed as median (range) Endotoxin-group I (fXlrified endotoxin) vs Sham-group 
.... 2 2 dead fetuses Endotoxin-group II (crude endo'toxin) vs Sham-group 
.... 3 one dead fetus HS: Nonsignificant ( p ~ 0.05) 
"'4 dead fetuses excLuded 
w 
TabLe 3.2. The influence of S.fragilis endotoxin on the OIeight of placenta and fetal liver'"' 
Placental OIeight (9) 
(n=33) 
Placental weigln:/Litter (9) 
(n---9) 
Fetal liver weight (9) 
(n=1S) 
Fe'tal liver weight/liner (9) 
(n:::S) 
Endotoxin-group 
(n=9) 
5.3 (3.3-8.7) 
5.3 (4.9-8.7) 
2.6 (2.4-4.0) 
2.8 (2.5-3.1) 
All data median (range) 
Endotoxin-group I : purified endotoxin 
Sham-group 
(n=9) 
5.2 (4.0-8.4) 
5.5 (4.6-8.1) 
4.1 (3.1-5.0) 
4.2 (3.7-4.6) 
"'S Nonsignificant ( p ;::: a.OS) 
p 
NS 
NS 
p < 0.0001 
p < 0.0001 
These conditions were only occasionally observed in studies with the endotoxin of the 
anaerobe B.fragilis in the pregnant guinea pig, where the significant impact was a 
reduction in fetal weight. These observations may indicate that not only the species of 
the host but also the biological activity of the infecting bacteria or injected endotoxins 
may influence the pathologic impact on the course of pregnancy. This hypothesis will be 
dealt with in chapter 6. 
The results of this study are in agreement with our earlier findings as reported in 
chapter 2 and support epidemiologic observations in pregnant women indicating that 
infections with gram negative anaerobes during pregnancy are associated with an 
increased incidence of fetal growth retardation56. 1I2,146. 
Chapter 4 will deal with the impact of B.fragilis endotoxin on some of the 
metabolic processes involved in fetal growth. 
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Chapter 4 
THE IMPACT OF B.FRAGILIS ENDOTOXIN ON MATERNAL AND 
FETAL METABOLISM* 
4.1. Introduction 
Fetal growth depends on complex adaptational processes in the mother. A 
variety of hormones and enzymes regulate the processing of nutrients stich as glucose, 
lipids and aminoacids by the maternal and fetal organism; disturbances in the regulatory 
mechanisms may lead to impaired fetal development. The resuits described in the 
preceding chapter show that a maternal challenge with endotoxin isolated from B.fragilis 
reduced fetal growth in the pregnant guinea pig, From studies in animal models it is 
known that endotoxins affect the carbohydrate and fat metabolism",l16,139, Endotoxins 
also induce prostaglandin synthesis, presumably throught stimulation of cyclooxygenase 
activity", This may explain the observed initiation of preterm labor, leading to late 
abortion and preterm delivery I29.i30, in cases of clinically manifest or subclinical 
maternal infections with E.coli or Bacteroides species. 
This chapter deals with experiments performed in pregnant guinea pigs in order 
to assess the impact of B.fragilis endotoxin on maternal and fetal metabolism of 
glucose, triglycerides, and prostacyclin, which could be involved in the observed 
reduction in fetal weight. 
4.2. Material and Methods 
Experiments were performed in nine endotoxin - and nine sham - treated 
pregnant guinea pigs between days 30 and 61 of gestation, 
The l1Iaill sub.flance of lhis chapfer was published ill : Beckmanll 1, Meisel-MikaYajczyk F, 
Leszczynski P, Brooijmfllls M, Wallellburg HCS. Am J Ob.uef GyJleco/ 1993; 168: 714-8,8 
33 
4.2.1. Extraction, isolation and pur((ication (?f endotoxin 
The extraction and isolation of B,/i"agilis IPL E 323 endotoxin are described in 
detail in chapter 2.2.1., the purification of the endotoxin is described in chapter 6. 
4.2.2. Allimals 
The animals used in this study are the same as those described in chapter 3.2.2. 
as endotoxin-group I and sham-group. 
4.2.3. Endoloxin atlminislralion 
Nine randomly selected animals were injected with a solution of purified 
B.fragilis IPL E 323 endotoxin dissolved in phosphate buffered saline (PBS) at pH 7.4 
(endotoxin-group I). The other nine animals received injections with the solvent only 
(sham-group). The scheme of intramuscular injections used in this study is described in 
detail in chapter 2.2.3. Complete Freund's adjuvant was used for the first injection in 
endotoxin - and sham - treated guinea pigs, all following injections were with 
incomplete Freund's adjuvant in both groups. 
4.2.4. Etperimelllal protocol 
Blood was collected on day 30 (maternal) and day 61 (maternal and fetal) by 
heart puncture under anesthesia as described in chapter 3.2.4. Blood samples were kept 
for 30 min at 37"C until clotting was complete and then centrifuged at 4"C and 1500 g 
for 10 min. The sera were stored at -20"C. Blood samples (2.5 ml) for the 
determination of maternal 6-keto-prostaglandin Fl. (POF I .,), a stable metabolite of 
prostacyclin (Pgl,), were collected in cooled plastic tubes containing 10 ILl of heparin 
and 25 ILl of indomethacin (0.1 % in phosphate buffer pH 7.4). The samples were 
centrifuged for 10 min at O"C and 1500 g and the plasma was stored at -20'C until 
analysis. 
4.2.5. Analylical procedures 
After deproteinization of the sera with 3.5 % perchloric acid at O°C and 
neutralization with ice-cold 0.12 mollL potassium carbonate, glucose was determined 
spectropholomelrically al 420 nm afler reaction wilh glucose oxidase, peroxidase and 
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2,2' -azino-di-(3-ethyl-benzthiazoline) - sulfonate lJ,,,, (Boehringer, Mannheim), 
Serum triglycerides were measured as described by Mendez et al. 108 after 
extraction with heptane and saponification with potassium hydroxide in isopropanol. 
Glycerol was determined spectrophotometrically at 415 nm after oxidation with 
period ate and reaction with acetylacetone. 
Plasma concentrations of 6-keto-PGFla were determined with a 
radioimmunoassay (E.1. Du Pont de Nemours-NEN Research Products, Boston). A Sep-
Pak CiS cartridge (Waters, Milford, Mass.) was prewashed with 10 ml of absolute 
ethanol, 10 ml of distilled water, and 2 ml of air. Two ml of plasma were applied to the 
column, followed by 2 ml of distilled water and 2 ml of air, The prostaglandin 
metabolite was eluated with 2 ml of absolute ethanol, followed by 2 ml of air, and the 
eluate was dried at 40'C under a gentle stream of nitrogen. The residue was dissolved 
in radioimmunoassay buffer, and the assay was performed according to the instruction 
manual82 . 
4.2.6. Slarislical analysis 
Data are presented as median (range) throughout. Wilcoxon's rank-sum and 
rank-sign tests were used to evaluate differences between measured variables. A value 
of p < 0.05 was chosen to represent significance. 
4.3. Results 
No signs of seriolls maternal illness in the pregnant animals were noticed during 
the period of endotoxin - and placebo - administration. 
4.3.1. Glucose illlllalNllal alldfelal plasllla 
There were no significant differences in maternal serum glucose concentrations 
determined on days 30 and 61 within groups or between the endotoxin and sham -
groups. Maternal and fetal values are presented in table 4.1. Fetal glucose levels on day 
61, expressed as percentages of maternal glucose concentrations, were significantly 
lower in fetuses of endotoxin - treated animals than in those of sham - treated controls. 
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4.3.2. Maternal alltlfetal triglyceride levels 
Maternal serum triglyceride levels on gestational day 30 were not different 
between groups. In endotoxin ~ treated animals maternal triglyceride concentrations on 
day 61 were significantly higher than those on day 30 (p<0.02). Such a rise was not 
observed in sham - treated guinea pigs. The median triglyceride concentration on day 61 
was 59 % higher in the endotoxin - treated compared with the sham - treated group 
(p<0.05). Also in fetal serum the median triglyceride level on day 61 of gestation was 
45 % higher in endotoxin - treated animals than in sham - treated controls ( p < 0.05 ). 
The results obtained on day 6 I of gestation are presented in table 4. I. 
4.3.3. 6-keto-PGFJ, ill lIIatemal plasma 
Table 4.1. shows the 6-keto-PGF" levels in plasma of pregnant guinea pigs after 
endotoxin and sham - treatment. The plasma level of 6-keto-PGF, of 29(17-93) pg/ml 
observed on day 61 in the sham - treated group was not different from that determined 
on day 30 {37(19-70) pg/ml} and before gestation {45{l8-61) pg/ml} in the same 
animals. 
The maternal plasma concentration of 6-keto-PGF" as determined on day 61 in 
endotoxin - treated animals was found to be t 7 times higher than that in sham-treated 
controls on day 61 (p<O.OOI). 
4.4. Discussion 
The resuits of this stndy show that in the pregnant guinea pig a maternal 
endotoxin challenge markedly affects glucose, fat and prostaglandin metabolism in the 
mother and glucose and fat metabolism in the fetus. 
It is known since many years that low blood glucose levels occur in several species 
following infection with endotoxin-producing gram negative bacteria63 ,109,]68. Animals 
injected with endotoxin initially exhibit hyperglycemia which turns into hypoglycemia 
with a decrease in hepatic and muscular glycogen". Shands et al.'39 and McCallum and 
Berry J06 found that endotoxin impairs the action of enzymes involved in gluconeogenesis 
from noncarbohydrate sources and in glycogen synthesis. In the present study significant 
hypoglycemia was demonstrated only in fetal plasma. 
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Table 4.1. MaternaL and fetal vatues of serllTl glul;ose and triglyc:erides and maternal plasm 6-keto-PGF, concentr"ations on day 61 of gestation 
in endotoxin-treated and sham-treated guine;;! pigs a 
Glucose (~9/mt) 
Median 
Range 
Glucose, fet:al I 
maternal ratio (%) 
Median 
Range 
Triglycerides (lLg/ml) 
Meelian 
Range 
6-keto-PGF1o: (pg/ml) 
Median 
Range 
Maternal values 
Endotoxin 
(n=9) 
2076 
1473-2705 
511 
322-'126 
499 
412- 798 
... NS nonsignificant (p ~ 0.05) 
Sham 
(n=9) 
1984 
1143-2334 
322 
248- 472 
29 
17- 93 
p 
NS" 
p <: 0.05 
p <: 0.001 
Fetal values/Litter 
Endotoxin 
(n"'9) 
739 
328- 975 
36 
15- 42 
2352 
973-4087 
Sham 
(n=9) 
912 
680-1288 
47 
33- 80 
1622 
1178-2141 
p 
NS" 
p <: 0.05 
p <: 0.05 
The lack of hypoglycemia in maternal plasma may be explained by the fact that 
maternal blood samples were obtained seven days after the last of five endotoxin 
injections. It should be noted that at this stage elevated hemagglutination titers, 
indicating marked formation of anti~endotoxin antibodies, were already detected. 
In the present study significantly elevated maternal and fetal plasma triglyceride 
levels were observed in endotoxin~treated animals. The induction of hyperlipidemia with 
elevated serum triglyceride levels during infection"·"·l" or endotoxin administration 
that has been observed in experiments with nonpregnant animals 14,n,IJ6 could be due to 
the effect of endotoxin on lipoprotein lipase (LPL) , the key enzyme of triglyceride 
metabolism'·'I.I35. Recent research has revealed that these metabolic effects of infection 
or endotoxin may be caused by cytokines, such as tumor necrosis factor a (TNF-a), 
produced by endotoxin ~ stimulated macrophages. Indeed, TNF~a has been shown to be 
capable of inducing hypoglycemia1,.".I52 and inhibiting lipoprotein lipase activity, thus 
reducing triglyceride removal. Injection of TNF~a in guinea pigs caused a marked 
decrease of mRNA levels for LPL in adipose tissue". After the endotoxin challenge we 
found a marked rise in the concentration of 6-keto-PGF,a in maternal plasma. which 
indicates an increase in proslacyclin synthesis, assuming the metabolic clearance has 
remained unchanged. Because maternal 6-keto-PGF,a concentrations in sham - treated 
animals were not different from control values obtained in untreated pregnant and 
nonpregnant animals, B.Jragilis endotoxin appears to stimulate the synthesis of 
prostacyclin in the pregnant guinea pig. This conclusion is supported by the observati~ 
ons that endotoxins46,t33,1441, and culture medium conditioned with or bacterial products 
isolated from B.jragilis I2 •97•98 cause an increase in prostaglandin production by human 
amnion and decidual cells. Endotoxin - induced enhancement of prostacyclin synthesis 
has been reported previolislyl05,114.i.'i.'i and seems also to be mediated by the action of 
cytokines. 
In conclusion, this study has shown that fetal growth retardation induced in 
pregnant guinea pigs by B.jragilis endotoxin, may be related to the observed alterations 
in maternal and fetal carbohydrate and fat metabolism, and in prostaglandin synthesis. 
Further investigation is needed to assess the complicated pathophysiologic interactions in 
this experimental model, in particular with regard to cytokine action. 
The next chapter deals with the putative role of tumor necrosis factor a in the 
response of pregnant guinea pigs to B.fragilis endotoxin. 
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Chapter 5 
ENDOTOXIN CHALLENGE AND RELEASE OF TUMOR 
NECROSIS FACTOR IX IN THE PREGNANT GUINEA PIG' 
5.1. Introduction 
In the previous chapters the effect of bacterial endotoxin on fetal growth in the 
pregnant guinea pig was described. After repeated administration of B.fragilis endotoxin 
fetal growth retardation associated with fetal hypoglycemia, fetal and maternal 
hypertriglyceridemia and a marked increase in maternal plasma prostacyclin 
concentrations was observed. Similar biochemical changes have been reported to be 
induced by the cytokine tumor necrosis factor a (TNF-a) in animal experiments and in 
man. This cytokine, mainly but not exclusively produced by activated macrophages·4.''', 
interferes with carbohydrate- and fat metabolism""", DNA-biosynthesis"·8l induces 
anemia8.~,113 and enhances prostaglandin synthesis Il4.1I6,155, The results as reported in 
chapter 3 and 4 may indicate that cytokines, especially TNF-a, are involved in the 
pathophysiologic mechanisms triggered by bacterial endotoxin and leading to fetal 
growth retardation. 
The present study was designed to test the hypothesis that BJragilis endotoxin, 
administered intramuscularly into pregnant guinea pigs, induces formation of TNF-a, 
associated with changes in the metabolism of glucose and prostacyclin as previously 
observed in endotoxin-induced fetal growth retardation. 
5.2. Material and Methods 
5.2.1. Extraction, isolation ant! purification of endotoxin 
The extraction and isolation of B.fragilis IPL E 323 endotoxin are described in 
detail in chapter 2.2.1., the purification of the endotoxin by treatment with nucleases 
and ultracentrifugation is described in chapter 6.2. l. 
Vie maill subs/alice of this chapter is ullder com1t/eratioll ill " Beckmanll I, LOlgering F, Meisel-
Mikotajczyk F, Rolmalls P, Wallet/burg HCS. Alii J O/)slet GYlleco/ 1994.6 
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5.2.2. Animals 
Experiments were performed in 12 randomly selected albino Dunkin-Hartley 
guinea pigs, at 30 days gestation. The first day of gestation was defined as the second 
day of the opening of the vaginal membrane". The animals were kept in individual 
cages in a controlled environment (l9'e, 50 % humidity, light/dark circle 13111 h), and 
were fed commercial guinea pig pellets, hay and water ad libitum. Vitamin e was 
added to the drinking water twice weekly. 
5.2.3. Experimental protocol 
On day 30 of gestation a polyethylene catheter was introduced into a carotid 
artery under general anesthesia, obtained with an intramuscular injection of ketamine-
hydrochloride (15 mg/kg body weight) and xylazine-hydrochloride (2 mg/kg bw). After 
recovery from the operation, as judged by restored weight gain, and 3 - 4 days after 
surgery! an arterial sample was taken from all animals for the determination of anti-
B.fragilis antibodies. The animals were then randomly divided into two groups of six, a 
sham-group with a median weight of 801 ( range 695-875 ) g and an endotoxin-group 
(median weight 814 (range 636-880) g). At 0 h the experiment was started with the 
intramuscular administration of 100 Ilg endotoxin Ikg body weight, dissolved in 100 III 
sterile phosphate buffered saline (PBS) at pH 7.4 and mixed with 100 III complete 
Freund's adjuvant, to the animals of the endotoxin-group. Guinea pigs in the sham-
group received an intramuscular injection of 100 III PBS mixed with 100 III complete 
Freund's adjuvant. Blood samples ( I ml) for the determination of TNF-o<, glucose and 
hematocrit were taken from the arterial catheter into heparinized tubes immediately 
before (sample 0) and 4, 7, 9, ll, 24 and 48 hs after the start of the experiment. For 
the determination of prostaglandin Fla (PGFla), the stable metabolite of prostacyclin, 
blood samples ( 1.5 ml ) were collected at 0, ll, 24 and 48 hs into cooled plastic tubes 
containing 10 III of heparin and 25 III of indomethacin (0.1 % in phosphate buffer pH 
7.4). Indomethacin blocks enzymes participating in the biosynthesis of prostaglandins 
and was used in order to prevent in vitro biosynthesis of prostacyclin by blood 
monocytes. The samples were immediately centrifuged for 10 min at 1500 g and 4'e 
and the supernatants stored at -80Ge until analysis. After each sampling of heparinized 
blood without indomethacin, the remaining erythrocytes were resuspended in saline and 
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returned to the animals through the arterial catheter. 
5.2.4. Stimulalion qfTNF-a release ill whole blood. 
This experiment was done to compare the time course of release of TNF-a by 
human and guinea pig l11onocytes in vitro, after stimulation in vitro with B.fragilis and 
E.coli LPS. 
A blood sample from a healthy nonpregnant female human donor and from a 
healthy pregnant guinea pig were collected into commercial EDT A vacuum tubes 
(Becton-Dickinson, Rutherford, NJ, U.S.A.). 0.5 ml blood was transferred into 6-wells 
tissue culture plates (Costar, Cambridge Ma, U.S.A.) and diluted 1:10 with RPMI 1640 
culture medium with 25 mM Hepes (Seralab Ltd., Drawley Down, U.K.), 
supplemented with 100 Viml penicillin, 100 ug/ml streptomycin, 4 mM I-glutamine and 
10 % fetal calf serum (Sebak GmbH, Aidenbach, Germany). The blood samples were 
stimulated with 25 it! PBS (controls), 10 ILl lipopolysaccharide (LPS) E.coli Olll B4 
(Sigma St.Louis U.S.A.) (I mg/ml PBS) or 25 ILl LPS B..f;·ogilis (I mg/ml PBS) and 
incubated at 37"C for 48 hs in a humified, 5 % CO2 atmosphere. Samples (I ml) were 
taken after 0, 6, 24 and 48 hs of incubation, centrifuged for 10 min at 1500 g and 4'C 
and the supernatants were stored at -80"C until analysis. 
5.2.5. Analytical procedures 
a. Antibody titers against B.fragilis endotoxin were determined in all O-samples 
by means of a hemagglutination test on microtiter plates, with endotoxin-coated sheep 
erythrocytes as antigens, as described in chapter 2. 
b. TNF-a in plasma and blood culture supernatants was assessed by 
bioassay"''', using the TNF-a-sensitive murine fibrosarcoma WEHI 164 cell line. Cell 
death was measured after 20 h of incubation at 37"C and 5 % CO2 by the colorimetric 
MIT (3-{ 4 ,5-dimeth ylthiaziol-2-yl}-2 ,5-diphenyltetrazoliumbromide, Sigma) assay". A 
standard titration curve, prepared with human recombinant TNF-a I was used to 
calculate TNF-a values from measured cytotoxicity. Neutralization of cytotoxicity in 
supernatants of human blood cultures was performed with a polyclonal rabbit anti-
human recombinant TNF-a antibody (Genzyme Cambridge, U.S.A.). The detection 
limit of the assay was 12 pg/ml. 
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c. Hematocrit values were determined by the microcapillary technique. 
d. The determination of glucose in deproteinized plasma was performed by 
spectrometry at 420 nm after reaction with glucose oxidase, peroxidase and 2,2'-azino-
di-(3-ethyl-benzthiazoline-sulfonate as described in chapter 4.2.5. 
e. Plasma concentrations of 6~keto~PGFla were determined with a radioimmuno~ 
assay (E.!. Du Pont de Nemours-NEN Research Products) as described in chapter 
4.2.5. 
5.2.6. Slalislieal analysis 
Friedman's two~way analysis of variance and Wilcoxon's rank~sum and rank-
sign tests were used to evaluate differences between variables within groups. A value of 
p < 0.05 was chosen to represent significance. 
5.3. Results 
Before the start of the experiments on gestational day 33 or 34, hemagglutination 
titers against B..fragilis endotoxin were < I: 10 in all animals. 
There were no signs of serious maternal illness during the course of the 
experiment. A ruffled coat was observed in most endotoxin-treated animals and 
disappeared 24 to 48 hs after endotoxin injections. 
5.3.1. Bioaclive TNF-a vailles in plasma 
Bioactive TNF-a was detected in plasma of five of the six animals in the 
endotoxin group, 9 hs after endotoxin administration, with a significant rise to a mean 
level of 400 pglml at I I h, followed by a significant fall to levels below the detection 
limit at 48 hs; in one guinea pig plasma weak TNF-a like cytotoxicity was found only 
at 24 hs. In the sham-group five out of six animals did not develop any bioactive TNF-
a within 48 hs; in one guinea pig plasma weak TNF-a like cytotoxicity was observed at 
11 and 24 hs. The results for all animals are presented in table 5.1. and figure 5.I.A. 
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TabLe 5.1. Bioactive TNF-a in pLasma of pregnant guinea pigs after endotoxin and sham-treatment 
hours 
after 
Injection 
o 
4 
7 
9 
11 
24 
48 
endotoxin - group 
(n"6) 
median range 
0 
0 
0 
65 0- 210 
215 0-161.0 
145 30- 600 
0 
5.3.2. Hematocrit vallles 
pLasma concentrations of TNF-a (pq/mll 
sham group 
(n"6) 
median range 
0 
0 
0 
0 
0 a-54 
0 0-36 
0 
The course of hematocrit values during the experiment is summarized in table 
5.2. and figure 5.I.B. 
TabLe 5.2. Hematocrit in pregnant guinea pigs after endotoxin and sham-treatment 
Hematocri t ~%) 
hours endotoxin group sham group p 
after (n=6) (n=6) 
injection 
median range median range 
0 36 34-41 37 33-42 N.S. 
4 36.5 33-38 35 32-38 N.S. 
7 35 29-40 35 33-39 N. s. 
9 34.5 25-40 33.5 31-40 N. S_ 
11 35 21-38 35 32-42 N.S. 
24 24.5· 12-36 35 33-40 ·p<0_03 
48 22_5· 18-36 34 31-39 ·p<O.03 
In the endotoxin-group hematocrit values were significantly reduced by 33 and 30 % at 
24 and 48 hs, respectively, after endotoxin injection. There was no significant change in 
hematocrit values in the sham-group during the course of the experiment. 
5.3.3. Glucose levels ill plasma 
A slight increase in plasma glucose levels nine to eleven hours after endotoxin 
injection was observed in five of six guinea pigs, but this increase was statistically not 
significant. There was a significant decrease of plasma glucose levels four hours after 
placebo injection in sham-treated animals. The results are summarized in table 5.3 and 
figure 5. 1. C. 
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TabLe 5.3. GLucose in plasma of pregnant guinea pigs after endotoxin and sham-treatment' 
Plasma concentrations of glucose 
endotoxin group sham hours 
after 
injection (Ilg/ml) (Ilg/ml ) 
o 
4 
7 
9 
11 
24 
48 
median 
995 
1003 
969 
1081 
1131 
928 
1040 
* endotoxin vs sham group 
range median 
823-1538 967 
772-1283 817 
829-1056 922 
898·1173 1014 
840-1270 1025 
878-1090 1036 
846-1245 1142 
N.S. = nonsignificant (p !: 0.05) 
5.3.4. prosracyclill levels ill plasma 
group P 
---
range 
858-1084 N.S. 
631,1034* *p < 0.03 
736·1268 N.S. 
722-1060 N.S. 
782-1060 N.S. 
796-1156 N.S. 
942-2500 N.S. 
6-keto-PGF" levels in the endotoxin-treated guinea pigs showed a significant 
rise after II hs ( p < 0.03), whereas no significant changes were observed in the sham-
group. The results are presented in table 5.4. and figure 5.1.0. 
Table 5.4. 
hours 
after 
injection 
o 
11 
24 
48 
6'keto'prostaglandin'F1a in plasma of pregnant guinea pigs after endotoxin and sham' treatment 
pLasma concentrations of 6-Keto·PGF,o:. ____ _ 
endotoxin' group 
median 
17.1 
65.9 
46.8 
56.3 
(pg/ml) 
range 
10.2' 35.0 
18.8'138.0 
' ....... ·,95.7 
20.3'285.0 
sham group 
(pg/mL) 
median 
31.3 
36.7 
18.2 
25.3 
range 
19.7'65.4 
3.8,61.8 
0.5-50 .... 
20.2'39.3 
p 
N.S. 
*p<0.03 
*p<0.05 
*p<0.03 
* = endotoxin vs sham'group N.S. '" nonsignificant (p :!: 0.05) 
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Figure 5.1. TNF-a, hematocrit, glucose amI 6-J...wo-PGFJo. in plasma of guil/ea pigs after i.m. 
administration of B.jragili.~ l'Iu/otoxill 01' p/ace/Jo. Endotoxin group = -, placebo group = - - -'-, 
IA.' TNF-a, IB.' heJJ/(/tocrit. Ie: glucos(·. ID.' 6-k()IO-PGFJo.' 1'(1111('.1' (/.\' fIImn {SEMj throughout. 
5.3.5. TNF-a released by guillea pig alld hUll1ol1 mOllocyles '{/ler slill1ulalioll wilh LPS 
isolated from B.fragilis and E.coli 
The results of the experiments with B..fragilis and E.coli endotoxin to stimulate 
release of TNF-a in guinea pig and human monocytes are shown in figure 5.2. 
Cytotoxicity in guinea pig samples followed a course similar to that in human blood. In 
human samples cytotoxicity was completely neutralized by anti-TNF-a antibody. 
Maximum secretion of TNF-Q: following B.fragilis endotoxin stimulation was reached in 
both cultures after 24 hs, whereas E.coli LPS stimulated TNF-a release in both cultures 
with a maximal response after 6 hs. TNF-a peak levels in supernatants of human and 
guinea pig blood cultures stimulated with E.coli LPS were higher than those reached by 
stimulation with B..fragilis endotoxin. 
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5.4. Discussion 
In pregnant guinea pigs TNF-a was detected 9 hs after administration of 
B.jragi/is endotoxin with peak values at 11 hs and a return to baseline levels after more 
than 24 hs. No reports of comparable experiments could be found in the literature. 
Zuckerman and Bendelel69 found that intraperitoneal administration of E.coli LPS (2 
mg/kg body weight) into nonpregnant guinea pigs caused a rapid rise of serulll TNF-a 
levels with peak values between less than 0.2 and 180 ng/ml 2 hs after injection and a 
return to base level after 6 hs. The difference in the time course and peak values of 
TNF-a between that study and the experiments in pregnant guinea pigs may be 
explained by the low concentration of LPS injected into the pregnant animals (100 
/Lg/kg body weight) and, in particular, by the intramuscular administration of the 
endotoxin, resulting in a much slower uptake into the maternal circulation than 
following intraperitoneal or intravenous injection. The intramuscular route was chosen 
to mimick chronic infection. 
The bacterial origin of the endotoxin may also influence the host's immunologic and 
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pathophysiologic response, Most studies involving the release of TNF-a after injection 
of endotoxins in mice used intravenously' or intraperitoneally administered LPS from 
gram negative aerobes, mainly Elllerobacferiaceae such as E.coli Of Salmonella species. 
There is evidence that the endotoxin of the anaerobe BJragi/is as used in this study is 
biologically less active than endotoxins isolated from El1Ierobacleriaceae lOI ,l42, This 
may add to a difference in peak levels of TNF-a stimulated by E.coli or BJragi/is 
endotoxin as observed in the stimulation experiments shown in figure 5,2, 
The neutralization of cytotoxicity in human blood supernatants by anti-hum an-
recombinant TNF-a antibody identified the cytotoxic agent as TNF-a, The lack of anti-
guinea pig TNF-a antibody and the low and irreproducible cross-reactivity of anti-
human TNF-a antiserum with guinea pig TNF-a precluded the exact identification of 
the cytotoxicity in guinea pig plasma, However, the similar time course of TNF-a 
release in human and guinea pig blood cultures after stimulation with BJragilis or 
E.coli LPS indicates that the released cytotoxic factor in guinea pig blood is indeed 
TNF-a, This is supported by the study of Tamatani et al. 150 who isolated and analyzed 
guinea pig TNF-a after stimulation of guinea pig macrophages by E,coli LPS, 
Additional evidence for this assumption is derived from the fact that the WEHl cell line 
used in this study to detect cytotoxicity in guinea pig plasma is specifically sensitive to 
TNF-a and insensitive to the cytokines as interleukin la (I1-la), interleukin 13 (II-1ft), 
interleukin 6 (I1-6) and interferon y (IFN-y)", 
The observation of significantly decreased hematocrit values in endotoxin-treated 
guinea pigs, 24 to 48 h after endotoxin administration, may be explained by 
microscopic blood loss in urine or stool, which was not controlled during the 
experiments, and the capacity of endotoxin or TNF-a to induce anemia in vivo by 
reducing the lifespan of circulating red blood cells and by interfering with 
erythropoiesis8.'i.l1J,I.<iI, 
Lethal doses of TNF-a in experimental animals have been shown to result in 
transient early hyperglycemia followed by hypoglycemia, both characteristic of septic 
shock", On the other hand, intravenous infusion of sublethal doses of TNF-a in 
endotoxin-tolerant rats left blood glucose levels unchanged, except for a small and 
transient increase 90 minutes after the start of the infusion l , Significant hyperglycemia 
was not apparent in the present study, possibly due to the low concentration and low 
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endotoxicity of B.fragilis endotoxin and its slow uptake into the circulation. The 
observation of a transient slight increase in plasma glucose levels 11 hours after 
endotoxin administration in five of the six guinea pigs may be an indication of the 
involvement of TNF-a in an endotoxin-induced effect. 
The effect of B.fragilis endotoxin on fat metabolism was not investigated in this 
study. Hypertriglyceridemia is known to occur 16 to 24 hours after intraperitoneal 
administration of lethal doses of E.eali or Salmollella LPS in mice",I36. In view of the 
low dose of B.fragilis endotoxin used in this study and the late appearance of TNF-a, a 
significant impact on plasma triglyceride levels during the short time course of these 
experiments could not be expected. 
The observation of a significant increase in circulating prostaglandin FIc~' 11 and 
24 hs after endotoxin injection, is in agreement with results of studies in humans in 
whom TNF-a was triggered by endotoxin, and was shown to cause increased levels of 
circulating prostacyclinl5s . An increased production of prostacyclin has also been 
observed after stimulation of guinea pig macrophages with endotoxin in vitroI47.148. 
In conclusion, this study shows that an intramuscular challenge with B.fragilis 
endotoxin in pregnant guinea pigs stimulates the release of TNF-a. The effects of TNFa 
on carbohydrate metabolism and fat biosynthesis in the pregnant guinea pig, together 
with the impact of TNF-a on DNA-biosynthesis,,·8J, may be responsible for the 
endotoxin - induced retardation of fetal growth observed in previous experiments. 
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Chapter 6 
STRUCTURAL llEATURES OF BACTEROIDES FRAGILIS 
ENDOTOXIN* 
liThe missing link" :2-Keto-3-deoxyoctonate 
6.1. Introduction 
Endotoxins, constituents of the ollter membrane of gram negative bacteria, are 
classically defined as high molecular weight complexes of lipopolysacharides (LPS) and 
proteins. There is convincing evidence that the lipopolysaccharide (LPS) moiety is 
responsible for most of the biological activities exhibited by bacterial endotoxin: 
pyrogenicity, local Shwartzman reaction, leucopenia and leucocytosis, hypotension, 
complement activation, mitogenic and blastogenic stimulation of B-lymphocytes and 
others (reviewed by Galanos and Freudenberg'o). The capacity of LPS to induce in 
mononuclear phagocytes synthesis and secretion of a cascade of endogenous mediators 
involved in the pathogenesis of sepsis or endotoxic shock has received particular 
scientific attention in the past ten years. Among these mediators are cytokines sllch as 
TNF-a, interleukins, arachidonic acid derivatives such as prostaglandin Ii, and 
prostacyclin, reactive oxygen intermediates, procoagulant factors, platelet activating 
factor and others (reviewed by Morrison ll '). 
Investigations into the structural components of LPS responsible for the initiation of 
mediator release from mononuclear cells are based on a detailed knowledge of the 
chemical structure of enterobacterial LPS. LPS from a great number of gram negative 
bacteria have common features. They consist of three structurally different regions: the 
lipid A moiety, the core oligosaccharide, and the complex O-specific polysaccharide of 
* 11Je main slilmmIC{~ of this chapter was published ill: BeckmallN /, I'all Eijk HO, Meisel-
Miko}ftjczyk F. Wallt'lIbllrg HCS, /111 J Biocl/em 1989;21:661-66(/°. 
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wild type strains, differing within and between species and carrying the serologic 
specificity of each strain 126 , The core oligosaccharide with a more limited stuctural 
diversity within the same bacterial genus consists of an "outer core It with common 
sugars such as glucose, galactose and N-acetyl-glucosamine, and an "inner core" made 
up in almost all enterobacterial and many nonenterobacterial LPS of I-glycero-D-manno-
heptose and 3-deoxy-D-manno-2-octulosonic acid (2-keto-3-deoxyoctonate) (KDO). The 
'inner core' sugars heptose and KDO are often substituted by phosphate, pyrophosphate 
or phosphoryl-ethanolamine. 
KDO is of vital nec,essity for the bacteria; blocking of the enzyme system leading to 
biosynthesis of KDO is lethal for gram negative organisms23 •126 ,I27. The attachment of 
KDO residues as a link between core oligosaccharide and lipid A is one of the early 
steps in LPS biosynthesisl2J. 
Lipid A, consisting of a 1110no- or di-phosphorylated 6-1,6-linked D-glucosamnine 
disaccharide substituted with ester and amid-bound long-chain fatty acids, has the same 
basic structure in practically all gram negative bacteria investigated so far. A schematic 
representation of the general structure of enterobacterial LPS is shown in figure 6.1. 
Studies on the role of structural components of LPS during activation of 
mononuclear cells have focussed on the lipid A region, which is responsible for many 
of the toxic activities of LPS J04 . It has been shown to be involved in receptor-mediated 
binding of LPS to macrophages and Illonocytes thus inducing a biological response in 
the mononuclear ce1l 27 ,87,166. The lipid A of B.fragilis, though structurally similar to 
E.coli lipid A, differs by its lack of the phosphate group on C, in the non reducing 
glucosamine and by the number and acylation pattern of long-chain fatty acids. In 
enterobacterial lipid A the glucosamine disaccharide is substituted by six to seven C12 ! 
C" and C,• fatty acids, predominantly 3-hydroxytetradecanoic acids. In contrast, lipid 
A of B.fragilis contains per two glucosamine residues five CIS and C 17 branched 
hydroxylated fatty acids, which are lacking in enterobacterial lipid A, and only traces of 
the 3-hydroxytetradecanoic acid. 
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Fig.6.1. Basic structure of an ~nterobacteriat L?S (modified after Lindberg et a[101 
GAL=gatactose, GlU=gLucose, GL CN=gLucosamine, GtcNAc=N-acetyLglucosamine, KDO=2-keto-3-deoxyoctonate, P=p/1osphate, S1-S4=sugar residues. 
Experimental evidence for the presence of carbohydrate-binding LPS receptors 
on macrophages and involvement of the core oligosaccharide structures in the 
stimulation of macrophages by LPS has been provided by the work of Haeffner-
Cavaillon et a1. Their results implicate the KDO residues as an important structural 
feature required for the release of interleukin-I from macrophages"·'oo. It has been 
claimed that certain bacterial genera, including the anaerobic Bacteroides species, form 
LPS that are deficient of KDO,,·90. Both features, KDO deficiency and a different lipid 
A structure, are held responsible for the low endotoxic activity of these bacteria 
compared with the, activity of Enterobacteriaceae such as E. coli or Salmonella 
species lOl ,142. 
The presence of KDO is normally detected by means of the widely used 
thiobarbituric acid assay (TBA)i6', after mild acid hydrolysis of the acid-labile ketosidic 
linkage of KDO with the following glucosamine disaccharide of lipid A'''. The TBA 
detects the 2-keto-3-deoxyaldonic acid contiguration ( HOOC-CO-CH,-CH(OH)-) that is 
present in 2-keto-3-deoxyoctonate and related compounds as 2-keto-3-deoxyheptulosonic 
acid or N-acetyl-neuraminic acid, a component of various strains of gram negative 
bacteria6-\, 103. 
Investigations by Le Dur et al. 99 of the TBA-negative LPS of Bordetella pertussis 
revealed that a negative TBA does not necessarily exclude the presence of KDO. In the 
LPS of Borde/alia pel'lussis KDO was substituted in position C, with phosphate and in 
position Cs with the sugar chain. Substitution in positions 4 and 5, or 5 and 7. prevents 
the formation of the thiobarbituric acid reactive fragment HOOC-CO-CH2-CHO, thus 
causing a negative TBA". Dephosphorylation of the LPS with 50% aqueous 
hydrofluoric acid prior to the TBA resulted in a positive response in the latter, thus 
indicating the presence of phosphorylated KDO in the native LPS. Brade et al." 
demonstrated for V.cllO/erae, another alledgedly KDO-deficient gram negative 
bacterium, the presence of phosphorylated KDO after strong acidic hydrolysis. 
Beckmann et al." detected 2-keto-3-deoxyaldonic acid in endotoxin isolated from 
Bacteroides Ol'alllS after hydrolysis with 2 M HCI. The 2-keto-3-aldonic acid was also 
detected in LPS isolated from Aeromonas salmollicidas. V.cholerae and Prevotella 
imermedia (Bacteroides imennedius) after dephosphorylation of the endotoxins with 
aqueous 50% hydrofluoric acid". These results prompted us to investigate the presence 
or absence of KDO in six reference strains of the Bacteroides Jragilis group, after 
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dephosphorylation of the endotoxins with hydrotluoric acid. 
6.2. Material and Methods 
6.2.1. Chemicals 
N-acetyl-neuraminic acid, 2-deoxyribose, 2-keto-3-deoxyoctonate ( as 
ammoniumsalt), crystalline bovine pancreatic ribonuclease and bovine pancreatic 
deoxyribonuclease were from Sigma, St.Louis, U.S.A. All other chemicals were 
obtained from Merck, Darmstadt, B R D. 
6.2.2. Bae/erial sfraim' 
Six reference strains of the B.frapJlis group were used: B.fhl'faiOlaomicron 
NCTC 10582, B.o)'a/lls ATCC 8483, B.I'lIlgatas ATCC 8482, B.dis/asolli.' ATCC 
8503, B.jragilis NCTC 9343 and B . fi'agilis IPL E 323. 
6.2.3. Erlracliol1 and iso/atiolt of ('IIt/oraxins amI purification (?f ([ lipopolysaccharide 
Bacteria were cultivated in yeast-broth medium l62 at 37°C for 48 hs. The 
cultures were centrifuged at 1500 g and the deposit collected. The bacterial bulk was 
extracted with hot aqueous phenol 16J , The water phase was dialyzed against tap water 
and distilled water, filtered through a Schott G5 filter, concentrated and lyophilized. 
The resulting substances were used as crude endotoxins. 
The crude endotoxin of strain B . fi'agilis IPL E 323 was puritied by 
ultracentrifugation and nuclease treatment 77. A 700 mg sample of the crude endotoxin 
was dissolved in 24 ml distilled water and ultracentrifuged for I h at I x 10' g in a 
Beckman ultracentrifuge LS-65. Pellet and supernatant were separated, the peliet 
dissolved in distilled water and lyophilized. Of the resulting substance 70 mg were 
suspended in 4 ml 0.15 M phosphate buffer pH 7.1, and incubated with ribonuclease 
and deoxyribonuclease in an enzyme:substrate ratio 1 :50 for 60 min at 37°C. After 
inactivation of the enzymes (12 min at 65°C) the solution was recentrifuged for 90 min 
at I x Il}' g in the ultracentrifuge. The supernatant was discarded, the pellet dissolved 
in distilled water, undissolved particles removed by centrifugation at 2000 g for 10 min, 
and the lipopolysaccharide was isolated by lyophilization of the clear supernatant. 
All experiments with crude endotoxin of B.fragilis and related strains and with 
the purified LPS of B.fragilis were performed in triplicate. 
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6.2.4. DephosphOlylation 0.( crude endotoxins aud pllrified LPS 
Dephosphorylation was performed according to Caroff et alY. A 5 mg sample 
of endotoxin or LPS was suspended in 300 It! aqueous 50% hydrotluoric acid (HF) and 
kept in sealed polypropylene tubes at 4'C for 48 hs. Volatile material was removed at 
room temperature by a stream of nitrogen, the residue dissolved in 300 /->1 distilled 
water and again dried by a stream of nitrogen. The dry residue was kept at -20'C for 
further analysis. 
6.2.5. Detennination of KDO ill cmde elldotoxins alld LPS by the thiobarbituric acid 
assay (TBA) 
A 2 mg sample of genuine LPS or 3 mg crude endotoxin or the corresponding 
residues after dephosphorylation with HF, were suspended in 50 resp. 100 1'1 0.25 M 
HCl and kept in sealed tubes for 8 min at 100'C. The hydrolysates, after cooling in ice-
water, were centrifuged at 4°C, (2000 g and 10 min), the residue washed with 50 resp. 
100 1'1 distilled water, centrifuged at 2000 g and supernatant and washing water 
combined. Aliquots of these solutions were used for the TBA and lor thinlayer 
chromatography. The TBA was performed according to the method of Karkhanis et 
al. 88. Aliquots of the hydrolyzed substances were transferred to fresh tubes and the 
volume adjusted to 100 1'1 with 0.125 M HCI. A 50 /->1 sample of 0.05 M HJ04 in 
0.125 M H2S04 was added and the solutions were kept at room temperature for 30 min. 
Excessive periodate was destroyed with 200 1'1 of 2 % NaAsO, in 0.5 M HCL. A 400 
1'1 sample of 0.6% thiobarbituric acid in water was added, the solutions were kept at 
100'C for 15 min and, when still hot, diluted with 400 /->1 dimethylsulfoxide. Absorption 
values at 549 nm were measured in a Zeiss photometer PM 2 DL, spectra registered in 
a Beckman spectrophotometer DK 2. 
For determinations with synthetic KDO, aliquots corresponding to 4-20 nM 
KDO in water, were adjusted with HCl to 100/->10.125 hydrochloric solutions. 
6.2.6. Thilliayer chromatography o.f KDO, related substances alld hydrolysates 
Commercially prepared TLC-plates with linear spotting zones (What man Inc., 
Clifton, U.S.A.) type LK 5 D, 0.25 mm thick, were used. The chromatograms were 
developed in n-butanol:acetic acid:water 2:1:1 80 , with the tank being equilibrated with 
the solvent before development of a chromatogram. Samples of synthetic KDO, 2-
deoxyribose and N-acetylneuratninic acid were applied as solutions in water, 
54 
hydrolysates as solutions in 0.125 M He!. Each chromatogram was run twice. After 
drying, the plates were stained with the thiobarbituric acid reagent l9 , 
6.2. 7. Delenllinalioll of nucleic acids 
A sample of I mg substance was dissolved in 10 ml 0.01 M NaOR and the 
nucleic acid content determined by absorption spectrometry at 260 nm with pure DNA 
as standard. 
6.3. Results 
6.3.1. Purificalion 'If Ihe endoloxin 
The yield of purified LPS aner nuclease treatment and repeated 
ultracentrifugation of the crude endotoxin was 7.6 %. The nucleic acid content of the 
crude endotoxin (70.5 %) was reduced to 12.4 % in the LPS aner the second 
ultracentrifugation. 
6.3.2. Reaclivity (if endoloxins in TBA b~fiJre and «(fier dephmphOl),lizalioll 
All preparations, crude endotoxins obtained from the six reference strains, and 
purified LPS of strain IPL E 323, before and after dephosphorylation, were investigated 
in the TBA aner short hydrolysis in 0.25 M ReI. Before hydrofluoric acid treatment, 
the endotoxins did not form the characteristic absorption maximum at 549 nm in the 
TBA, whereas all six endotoxins after dephosphorylation reacted with spectra as shown 
in figure 6.2. for the crude endotoxin of B.fragilis IPL E 323. 
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Fig. 6. 2. TBA response 
of J mg crude flldmoxin, 
isolatedfrom B.fragilis iPL E 323. 
before rA) alit! after (B) 
dephosphOJ)'larioll 
with 50% hydrofluoric lIcid. 
The reactivity of the purified LPS in TBA before and after dephosphorylation is 
presented in figure 6.3. 
, 
6.3. TBA-response of 1 mg purified LPS, 
isolatedfrom B./mgilis iPL E 323, 
before (AJ alld after (8) depliosphmylafioll 
with 50% hydrofluoric acid 
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6.3.3. The idellliry of 2-ke/o-3-deoxya!doflic acid 
The identity of the 2-keto-3-deoxyaldonic acid detected by TBA in the LPS of 
IPL E 323 was further investigated by means of thinlayer chromatography. N-
acetyl neuraminic acid, 2-deoxyribose and 2-keto-3-deoxyoctulosonic acid were applied 
together with the acidic hydrolysate of the dephosphorylated LPS. The Rrvalue of the 
TBA-reactive substance in the hydrolysate was identical with that of synthetic KDO as 
demonstrated in figure 6.4. 
2 4 3 4 2 
Fig. 6.4, IhiJJlayer chromatography of refe/'ence slIb.\'/aIlCCS 
{/lid fhe acidic hydrolysate of B,jragi/i,\' IPL E 323 LPS 
ill lI-blltllllOi:acelic add:Ii'ala 2: 1,' J, 
Stain: thiobarhiwric acid reagenf. 
lalle 1.' N-acefyllleuramillic acid, 
lalle 2: KDO, 
lalle 3: 2-deoxyribose. 
falle 4: hydrolysate of LPS B.fragilis IPL E 323. 
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6.3.4. Qllalllificalioll q{ KDO ill B.,fragilis IPL E 323 LPS 
KDO is acid-labile and, when released from a lipopolysaccharide by acidic 
hydrolysis, it is partially destroyed during the procedure. In order to evaluate the 
amount of KDO lost during dephosphorylation and hydrolysis, 100 I'g KDO were 
dissolved in 300 1'1 aqueous hydrofluoric acid and treated as described for endotoxins 
and LPS. After hydrolysis at lOO'C in 0.25 M HCI for 8 min the KDO-content of the 
solution was determined quantitatively by means of the TBA. Of the employed KDO, 
20 % were lost after treatment with HF and hydrolysis, as being calculated from 
reference values obtained for untreated, unhydrolyzed KDO. The KDO-content of 
B.fl·agilis IPL E 323 LPS was determined from the absorbtion at 549 nm in the TBA, a 
destruction of 20% of the liberated KDO during dephosphorylation and hydrolysis, and 
a nucleic acid content of 12.4% and was calculated to be approximately 15 nM/mg 
LPS. 
6.4. Discussion 
It was shown in this chapter that KDO is a normal constituent of endotoxins 
isolated from B.,fragilis and the five related strains. The reactivity in the native 
endotoxin and the positive reaction after treatment of the latter with hydrofluoric acid, a 
highly specific dephosphorylating agent'O', indicates that KDO in these endotoxins is 
substituted by at least one phosphate group. KDO can also be liberated from 
Bacteroides endotoxins by 2 M HC1, but is easily destroyed during the strong acidic 
hydrolysis". 
Dephosphorylation of the LPS - bound KDO prior to mild acidic hydrolysis, as 
applied for the TBA, has the advantage of a less rigid destruction of the liberated KDO. 
The reduction of reactivity during the TBA was mainly a result of the mild acidic 
hydrolysis, as shown by the quantitative determinations conducted with synthetic KDO. 
The identification of the 2-keto-3-deoxyaldonic acid as ketodeoxyoctonate was 
achieved by means of thinlayer chromatography in which the acid comigrated with 
synthetic KDO and could be clearly differentiated from N-acetylneuraminic acid. 
Compared with KDO-values reported for enterobacterial LPS with 3 KDO 
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molecules in the inner core, the KDO content in the LPS of B.fragilis IPL E 323 is 
low. This is in accordance with reports of other nonenterobacterial LPS with only one 
molecule phosphorylated KDO in the inner core23 .95 ,127, 
Results of investigations on involvement of KDO-containing inner core structures 
of LPS in the stimulation of mononuclear cells to release TNF-Ct are still controversial. 
Studies with monoclonal antibodies directed against epitopes in the inner core structure 
of LPS seem to indicate that these regions are also involved in the development of 
endotoxicity in general, and in the induction of TNF-Ct release from macrophages!26. In 
this context the findings reported by Haeffner - Cavaillon" are of interest; they show 
that the weak induction of interleukin-I by LPS of V.ella/erae and B.pertussis with one 
phosphorylated KDO in the inner core, was increased after removal of the phosphate 
group of KDO by treatment with hydrofluoric acid, thus involving the KDO residue in 
the events leading to II-I release from mononuclear cells. 
In conclusion, the results presented in this chapter show that KDO, probably one 
of the structural requirements for endotoxic activity, is present in B.fj'agilis endotoxin. 
Phosphorylation of the ketodeoxyoctonate and a low KDO content of the LPS may be 
structural features of the B.jiYlgilis LPS contributing to a lower endotoxicity as 
compared to that of enterobacterial endotoxins. 
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Chapter 7 
BACTEROIDES FRAGILIS ENDOTOXIN IN THE I''ET AL 
COMPARTMENT AND SOME OF ITS (pHYSICO)CHEMICAL 
CHARACTERISTICS' 
7.1. Introduction 
Following parenteral administration lipopolysaccharides (LPS) have been 
detected in variolls tissues of several animal species47.92 and in blood cells such as 
mononuclear cells, granulocytes and platelets"''''''. E.coli LPS could be demonstrated 
in liver, lung and spleen for at least four weeks after intravenous injection in rats47 • The 
few reports on the capacity of endotoxin to cross the maternal/fetal barrier show 
controversial results. Evidence for transplacental transfer of E. cali and S.1)1Jhi antigens 
in pregnant women was provided by Cramer et al,Jl, Dzvonyar et aI. J4 detected E. coli 
endotoxin in the fetal placenta, skin, kidney, lung and liver of endotoxin-treated 
pregnant rabbits, but Parant and Chedid26 ,122 failed to demonstrate E.coli or S.enlerifiliis 
endotoxin in the fetal compartment after injection into pregnant mice. Romero et ai. 130 
showed that E.coli endotoxin did not cross chorioamniotic membranes in vitro. 
In the study of the immune response to crude B.fragilis endotoxin in pregnant 
guinea pigs reported in chapter 2, IgM-type anti-endotoxin antibodies were observed in 
fetal plasma and amniotic fluid. As discussed in chapter 2, this could be due to transfer 
of IgM across the yolk sac, but it may also be a consequence of transfer of B.fragilis 
endotoxin from mother to fetus followed by induction of production of specific fetal 
IgM. The possibility that tile endotoxin could have penetrated the placental barrier in 
the pregnant guinea pig was assessed in experiments in amniotic fluid from two 
endotoxin-treated and two sham-treated guinea pigs and some (physico)chemical 
characteristics of the endotoxin were determined. 
* Ihe methodological approach to detect BJragilis elldotoxin ill amlliotic fluid is accepted for 
publication as,' Beckmalill I, de GraaffK, Meisel-Mikof{yct,yk F, Wallellburg H.C.S. Deteetioll of 
Bacteroides ji'agi!is elldotoxin ill amlliOfic fluid by ollllferiml1lUIIOeleclrophoresis. AIlfOllie \'all 
Leeuwenhoek 19947, 
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7.2. Material and Methods 
7.2.1. Chemicals and n/(/Ierials 
Trypsin (bovine pancreas) and pronase (Slr.griseus) were from Sigma (U.S.A.), 
all other chemicals from Merck Germany). 
Ultrafilters UFC3 LCCOO (molecular weight (MW) limit MW < 5000 D) and 
UFC3 LGCOO (MW limit MW < 10000 D) were from Millipore B.Y., Etten-Leur, 
the Netherlands. 
7.2.2. A11lisera 
Rabbit antiserum against B.fragilis IPL E 323 was prepared as described in 
chapter 2. 
Goat anti-rabbit antiserum was a gift from Dr.B.Kickh6fen, Max Planck Institut 
fUr Immunbioiogie. Freiburg, Germany, 
7.2.3. AII/niolic fluid samples 
Amniotic fluid samples from two endotoxin-treated and two sham-treated guinea 
pigs that were used as experimental animals in the study described in chapter 3, and 
amniotic fluid from a nonimmunized healthy guinea pig were assessed for the presence 
of B.fragilis endotoxin. The amniotic fluids were obtained on gestational day 61, 
centrifuged for 10 min at 4"C and 1500 g and stored at -20"C until analysis. 
7.2.4. Et/raclion, isolalion and purificalion l?f B.fragilis IPL E 323 LPS 
The extraction of B,.fi'agilis IPL E 323 bacteria with phenol/water, the isolation 
of crude endotoxin and purification of the LPS by nuclease treatment and ultra-
centrifugation are described in chapter 6. 
7.2.5. Single radial imll/unodiffusion (Mancini) leslfor Ihe deleclion qf B.Fagili,\' LPS in 
amllio/ie fluhl 
Microscope slides were precoated with a solution of 0.1 % agarose in Laurell 
buffer pH 8.4. Agarose ( I % in Laurell buffer pH 8.4) kept at 56"C, was supplemented 
with B.fragilis IPL E 323 antiserum (1:5 diluted with PBS) in a concentration of 20 1'1 
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serum / 2 Illi agarose. Of this mixture 2 Illi were put on precoated slides. After 
solidification of the agarose layer holes with a diameter of 3.5 mm were cut and filled 
with an antigen solution in amniotic fluid, amniotic fluid of experimental animals or 
controls (amniotic fluid of healthy nonimmunized guinea pigs). The slides were kept in 
a humid chamber at 4"C for 48 hs. Antiserum was washed out of the agarose layer by 
PBS at 4"C in a humid chamber for 72 hs with repeated changing of the washing fluid. 
To each hole 3 III of goat anti-rabbit antiserum were added, the slides were again 
incnbated for 24 hs and washed for two days with PBS. After drying, the precipitates 
were stained with Coomassie Brilliant Blue G 225 as described by Weeke"'. 
7.2.6. Ultrafiltration and coulllerimI11Ulloe/ec/roplioresis for the detection of B.fragilis 
LPS ill IIII/Iliotic .lluit! 
Amniotic fluid was heated for 5 min at lootlC in order to dissociate 
antigen/antibody complexes and centrifuged at 1500 g and 4"C for 10 min. 400 III of 
the supernatant were transferred into an ultrafilter (5000 D) and centrifuged for 60 min 
at 2000 g and 20nC. This procedure resulted in an concentration factor of approximately 
10. 
Counterimmunoelectrophoresis (CIE) was performed on microscope slides 
precoated with O. I % agarose in Laurell buffer pH 8.4 and covered with 2 ml of 
agarose gel (1 % in Laurell buffer). Two rows of holes (diameter 3.5 mm) were cut 
with a distance of 3 mill between rows. Six ttl of the testsolution ( amniotic fluid and 
controls) were put into the holes on the cathodic side of the slide, 8 III of antiserum 
were put into the holes on the anodic side. After electrophoresis for 45 min at a field 
strength of 3.2 V/cm and 20"C, the slides were incubated over night at 4°C in a humid 
chamber, washed for 48 hs at 4"C with PBS and stained with Brilliant Blue G 225. 
7.2.7. Grabar imlllulloelectrophoresis <If B./ragilis lPL E 323 elldotoxill 
The electrophoresis was performed as described in chapter 2.2.7.d. After 
electrophoresis of the endotoxin and application of the antiserum to the central trough 
the slides were kept in a humid chamber at 4"C for 24 to 48 hs until immunoprecipitates 
were formed. After extensive washing in PBS at pH 7.4 for 48 hs the agarose layers 
were dried and stained with Brilliant Blue G 225. 
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7.2.8. Periodole oxidolioll q/ B .. fi·ogilis I PL E 323 elldoloxill 
B.fragilis endotoxin was oxidized with periodate" and the oxidized product 
compared in Grabar immunoelectrophoresis with an endotoxin sample, sham-treated 
with the same procedure but with phosphate buffer instead of sodium periodate. 
One ml of a 0.05 M sodium periodate solution in phosphate buffer (pH 7.0) was added 
to a solution of 2 mg crude endotoxin in I ml phosphate buffer, and the mixture was 
incubated at 4'C in the dark for five days. Periodate was destroyed by addition of 150 
I.d diethyleneglycol, the mixture dialyzed over night against distilled water and the 
solution concentrated under vacuum to a final volume of I ml, to which 900 J1.g NaCI 
were added. 
7.2.9. EIlZYlllalic digeslioll qf B..fi·ogilis IPL E 323 elldoloxill 
Crude B./ragilis endotoxin was treated with the proteolytic enzymes trypsin and 
pronase to assess the presence of a protein component. 
A volume of 100 J1.1 of a solution of I mg trypsin I ml phosphate buffered saline 
pH 7.4 (PBS) and 100 III pronase (I mg/ml PBS) were added to 0.5 ml of a solution of 
endotoxin in PBS (I mg/ml). The mixture was kept at 37"C for 20 hs, and the enzymes 
were inactivated by addition of formaldehyde to a final concentration of 0.2%. 
7.3. Results 
7.3.1. Elldoloxill B..fragilis IPL E 323 ill allllliolic.f/Ilid salllpies 
Figure 7.1. shows the results of a Mancini test with amniotic fluids obtained 
from two endotoxin-injected. one sham-treated and one nonimmunized guinea pig. The 
detection limit for B,.fi'agilis IPL E 323 endotoxin in this test was 125 ng/ml. 
A distinct precipitate was visible around the hole which contained amniotic fluid from 
an endotoxin-treated guinea pig (hole 5). The concentration of B.fragilis endotoxin in 
amniotic fluid of the second guinea pig (hole 2) is lower than in the first one and near 
the detection limit for this assay. There were no precipitates around holes which 
contained amniotic fluid from a nonimmunized (hole I) or sham-treated guinea pig (hole 
6). Amniotic fluid with added B./ragi/is endotoxin or purified LPS reacted with a solid 
precipitation ring (holes 3 and 4). 
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Fig. 7. J. Mal/c/llifest 11';111 B.fmgi/i.f IPl. E 323 rabbit muisenll1/ (bac/erla) and goal allll-rabbit [g-
mU/serum ill lite aga/"Ose layer alld }: Amlliollc fluid (AF) of (/ lIollillllllllllized guillea pIg, 2; AF oj all 
endotoxin-treated gllillCll pig, 3: AF 1I';lh crude elld%xill B.fragilis 3 PClml, 4; AF willi LPS B.fragills 3 
P81m1, 5: AF of all elld%xin-treated guillea pig, 6: AF of a sllalll treated gllillea pig 
Samples of amniotic fluid of endotoxin and sham-treated guinea pigs were 
concentrated and investigated in eIE as shown in figure 7.2.a. and b. 
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Fig.7.2.a. alld h. o:pholographlc pic/lire: b:schemalledrall.illg.Allllliotic fluid of (wo elida/axil/-treated 
alld 111'0 shall/-treated gllillea pig.s ill (he CIE fest. Roll' to [he (II/ode: rabbit allli-B.fragili.s /PL E 323 
alliiscrum (bacteria), row to the cathode: (I) AF of guillea pig I after elldotoxill-trea/mellt, (2) AF of a 
sham-treated guil/eo pig. (3) AF of guillca pig II ofler elldotoxin trcalmellt, (4) AF of a shall/-treated 
guillea pig, (5) - (8) LPS B.jrogili.{ (l IJC/IIII) dUll/cd 1:1 lI'ilh Illlllliatic fluid of a immullizcd healthy 
guillca pig, (9) AII/lliolic fluid of a hcalllly 1I0llim/lIlfIJiud guillea pig. 
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The CIE - picture shows that antigenic components of B.fragilis endotoxin, reacting 
specifically with the homologous antiserulll, were detected in amniotic fluid of two 
endotoxin-treated guinea pigs. No immune precipitates were visible in the amniotic fluid 
of the two sham-treated animals. 
The immune precipitate in amniotic fluid of the second endotoxin-treated guinea pig was 
faintly perceptible on the original slide; it is obscure on the photographic picture but 
indicated on the schematic drawing. The detection limit for the assay was 500 ng/ml, 
which is equivalent to 50 ng/ml after tenfold concentration of the amniotic fluid. 
7.3.2. 77J1' allligel/ic campol/ellls qf B.fragilis IPL E 323 el/doloxil/ 
The antigenic pattern of B . .fragilis IPL E 323 crude endotoxin and purified LPS 
which were used in the studies reported in this thesis, was assessed by Grabar 
immunoelectrophoresis. The results are shown in Fig.?3. 
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Fig. 7.3,: Gmbar illlllllllloe/eclroplwresis wilh crude elldoloxi" 
alld pI/fijii'll LPS from B,jmgilis IPL E 323 a,\' amigellS 
alld rabbit ollti - 8.jmgiliov IPL E 323 ami.I'C'I'UIII. 
Right: B,fragili.~ IPL E 323 c/'/Ide l'lItiofoxill, 
left: B,jragi/i.\' IPL E 323 pl/rijied LPS. 
Mhid/e: B.Jrt/gi/is IPL E 323 1II1tisertll1l (rabbits). 
The Grabar immunoelectrophoresis shows that the crude endotoxin is antigenically 
heterogenolls. The purified LPS contains less, but still several, distinct components. 
After periodate treatment of the endotoxin all antigenic components present in the 
original and the sham-treated endotoxin, had disappeared. Endotoxin treated with the 
proteolytic enzymes trypsin and pronase gave the same picture as the original 
endotoxin, 
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The capacity of antigenic components in BJragilis LPS to pass the ultrafiltration 
membrane, used for concentration of amniotic fluid before CIE, was investigated. 
B.fragilis LPS was added to amniotic fluid of a healthy, nonimmunized guinea pig and 
concentrated by filtration through ultrafiltration membranes with molecular weight limits 
of 5000 and 10000 D. Residues and filtrates were investigated in Grabar 
immunoelectrophoresis and CIE. In the filtrate of the 5000 D filter no antigenic 
components were detectable by CIE; the residue ( > 5000 D) contained all antigenic 
fractions of the original LPS. 
After concentration of the LPS solution in amniotic fluid with a 10000 D 
ultrafilter all antigenic components of the original solution were still present in the 
residue, but CIE of the filtrate showed that some antigenic components had passed the 
filtration membrane. The CIE results are presented in figure 7.4. 
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Fig. 7. 4. ctE wilh tlte filtrate of II soimioll of B.fragilis LPS ill lImlliotic fluid after COJ/celltrat/Oll wilh a 
1O<XXJ D ultrafilter (row (o fhe cathode), alld rabbit lIlIli-B.fragilis allfisemlll (bactcria) (row 10 the 
anode). 
7.4. Discussion 
The results of a small number of experiments with Mancini tests and 
counterimmunoelectrophoresis to assess the transfer of BJragilis endotoxin through the 
placental barrier show that antigen-reactirig components of the endotoxin were present in 
amniotic fluid. In both tests amniotic fluid from sham-treated guinea pigs, before and 
after concentration, did not produce any immune precipitate; the observed precipitate is 
specific for BJragilis endotoxin. The concentration in the two samples from endotoxin-
treated animals was low, in one sample approximately between 250 and 125 ng/ml, in 
the second sample less than 50 ng/ml. This sample produced only a faint immune 
precipitate at the detection threshold of both assays. The results are in accordance with 
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observations of Dzvonyar et al:", who investigated the distribution of P"-Iabeled E.coli 
endotoxin in pregnant rabbits and their fetuses and found the majority of endotoxin in 
maternal and fetal placentas and fetal skin and kidney, and only low quantities in blood 
and amniotic fluid. 
The transfer of maternally injected BJragilis endotoxin to the fetus as already observed 
for E.coli endotoxin in pregnant rabbits" would explain the presence of specific IgM in 
fetal sera and amniotic fluid and may be a challenge for fetal immunocompetent cells to 
produce immunologic mediators. 
Additional experiments performed to characterize the crude and purified 
endotoxin used in all studies of this thesis show that it is antigenically heterogenous. 
Purification by nuclease treatment and ultracentrifugation removed the majority of 
nucleic acids and reduced the number of antigenic components in the LPS which, in 
immunoelectrophoresis, still displays at least three antigenically different components. 
This is in accordance with a study of Hofstad7]. who reported similar results with the 
same strain of B.Jragilis. 
Kasper et al.\)O determined the molecular weight of the LPS monomer isolated 
from a related B.fragilis strain as approximately 12000 D. FiUration of the LPS isolated 
from B.jragilis IPL E 323 in amniotic fluid through uUraliUers with a molecular weight 
limit > 10000 or 5000 D showed that the smallest antigenically reactive component in 
the LPS preparation used in the studies reported in this thesis had a molecular weight 
between 5000 and 10000 D, lower than the value determined by Kasper for the LPS of 
B.fragilis NCTC 9343 but in accordance with estimated values for LPS with a similar 
basic structure4B • 
LPS from B.jragilis strains, extracted and purified by different methods, can be 
contaminated with capsular polysaccharide antigens of high molecular weight 
(approximately 1.5 x 10' D'20), which are also important virulence factors of the species 
B.jragilisJJ9• A complete separation of both cell wall antigens with nonaggressive 
methods, which leave the primary structure and conformation of these macromolecules 
intact, is not easily achieved and was not the aim of this study. But the molecular 
weight range, the presence of KDO which is absent in the capsular polysaccharide, and 
the biological activities of the crude endotoxin and purified LPS used in these studies 
indicate that these preparations indeed contain the endotoxic cell wall 
lipopolysaccharide. 
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Chapter 8 
GENERAL DISCUSSION 
Endotoxins (lipopolysaccharides) are important factors in the development of the 
clinical sequelae of infection of the pregnant woman with gram negative bacteria. Some 
of the complications could be associated with the capacity of endotoxin to elicit the 
release of effector molecules which regulate the pathophysiologic response of the 
host27•5O • Most studies on this subject deal with endotoxins isolated from gram negative 
aerobes such as Enterobacteriaceae, but the anaerobic Bacteroides species are the most 
often isolated anaerobic bacteria in obstetric and gynecologic infections", and they are 
known to be involved in abortion I I 1.143 and preterm labor9J ,94,111,1I2. These organisms 
have also been shown to be associated with low birthweight; but the pathophysiologic 
mechanisms in mother and fetus have not been explored. 
This thesis presents an attempt to assess effects of endotoxin isolated from B.fragilis on 
the maternal and fetal organism and especially on fetal growth, with the pregnant guinea 
pig as the experimental animal. The endotoxin was injected intramuscularly, a route of 
administration that results in a slower uptake into the maternal circulation than 
intravenous or intraperitoneal injection. This route was chosen to mimick chronic 
bacterial infections. The choice of a guinea pig model was based on the similarity of the 
human and guinea pig placenta and the length of gestation, which allows for 
immunization schedules with sufficient antibody production. 
In the first study presented in chapter 2, the antibody response to B.jragilis endotoxin 
was investigated. Pregnancy may be expected to be associated with a nonspecific 
immune suppression in the context of tolerance to the fetal allograft, as observed in 
pregnant guinea pigs after immunization with haptenated protein antigens69 ,160. 
However, the humoral immune responsiveness to B.fragilis endotoxin in the pregnant 
animal was unsuppressed. There was no decrease in maternal IgM levels in the early 
primary response, and no impaired IgG response in the later stages. The response to 
proteinic antigens is T-cell dependent, whereas B.fragilis LPS has been reported to 
mediate in mice T-independent B-cell stimulation76.".I". At the end of gestation fetuses 
responded with IgM and IgG antibodies to maternal immunization with endotoxin. The 
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source of IgM antibodies could be maternal if pregnant guinea pigs, like pregnant 
rabbits, transfer IgM through the yolk sac splanchnopleur to the fetus"·67. But the IgM 
in fetal sera could also be produced by antigen-stimulated fetal B-eells. The results of 
two experiments, described in chapter 7, suggest that the immune system of the fetus 
may be stimulated by antigenic components of B.fragilis endotoxin transferred into the 
fetal compartment. 
The first study showed that crude B.ji'agilis endotoxin administered intramuscularly 
during the second half of pregnancy was associated with a reduction in fetal weight. 
Further experiments to assess the influence of B..fragilis endotoxin On the development 
of maternal and fetal weight are described in chapter 3. These experiments conllrmed 
the observations that B.fragi/is endotoxin, administered over the second half of 
gestation, indeed reduces fetal weight signitlcantly. The observation of an unaffected 
placental weight but a significantly reduced fetal liver mass points towards an effect of 
B.fragilis endotoxin on maternal and fetal metabolism with an unimpaired uteropiacentai 
blood flow. This metabolic effect was investigated in more detail in the experiments 
described in chapter 4. 
An endotoxin challenge in the pregnant guinea pig resulted in fetal hypoglycemia, 
maternal and fetal hypertriglyceridemia, and in increased prostaglandin F I, levels in 
maternal plasma. These experimental findings show that the known impact of 
enterobacterial endotoxins on glucose- and fat metabolism and prostaglandin 
synthesis46,71,91 are also produced by endotoxin from the anaerobic B.fragilis. These 
metabolic consequences of an endotoxin challenge could be involved in the observed 
reduction of fetal growth. 
Because it is known that the observed metabolic changes can be produced by tumor 
necrosis factor_a28.J6,R",.lS,\ released mainly but not exclusively from macrophages after 
stimulation with endotoxin, the possible contribution of this potent cytokine was 
investigated in more detail in the experiments reported in chapter 5. It was shown that 
intramuscular administration of B.fragilis endotoxin stimulated in first instance the 
release of bioactive TNF-a, followed subsequently by decreased hematocrit values, 
increased prostacyclin levels and a slight and transient increase in plasma glucose 
concentrations. By comparison with intravenous or intraperitoneal administration of 
enterobacterial LPS, the induction of TNF-a release after intramuscular injection of 
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B.fragilis endotoxin was slow and resulted in lower levels of TNF-a. In vitro 
experiments, to compare the induction of TNF-a release in guinea pig and human blood 
monocytes by E.coli and B..fragilis endotoxin, confirmed the results obtained in vivo in 
pregnant guinea pigs. The slow release of TNF-a with low top levels is most likely 
caused by the intramuscular route of administration, with a slow uptake of the endotoxin 
into the circulation, and could also be attributed to a "low endotoxicitylt of the 
anaerobic B.fragilis by comparison with the highly endotoxic E.colilOl.142. 
It has been suggested in the literature75 •9Cl that Bacteroides species lack certain structural 
features involved in the expression of endotoxic activities such as the induction of 
interleukin-l release from macrophages. However, the results described in chapter 5 
indicate that injection of B.fra~ilis endotoxin induced in pregnant guinea pigs the release 
of another cytokine, TNF-a. In the study presented in chapter 6, it was demonstrated 
that one of the missing structural features, the uinner core u constituent 2-keto~3-
deoxyoctonic acid (KDO), is present in the endotoxin of B . ./i'(lfiilis, but that substitution 
with a phosphate group not only prevented its detection in previous studies but could 
also be a cause of a reduced capacity to induce cytokine release. This assumption is 
supported by the observation that dephosphorylation of KDO in V. cholerae LPS 
increased the capacity of this LPS to induce the release of interleukin-l from 
macrophages65 . 
KDO as an inner core constituent seems to be involved in the binding of LPS to LPS 
receptors on the macrophage which are responsible for the transmission of the signal for 
cytokine release27 • Whereas the strong induction of release of TNF-a by the highly 
endotoxic LPS of E.coli and other Elllero/J(lcleri(lce(/e leads to early abortion or fetal 
death, the lower endotoxicity of the B.fragilis LPS in a low-dose intlux during chronic 
infection may lead to a less marked but still effective impact on fetal metabolism and 
growth. 
In conclusion, the studies presented in this thesis show that Bacteroides /ragilis 
endotoxin, when injected into the pregnant guinea pig, stimulates a humoral immune 
response, reduces fetal weight, induces the release of TNF-a and prostacyclin into the 
maternal circulation, and induces changes in maternal and fetal carbohydrate and fat 
metabolism that are related to a decrease in the fetal liver mass. These results support 
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the hypothesis that Bacteroides /ragilis, a common constituent of the cervical and 
vaginal flora and an important contributor to intrauterine infections, may induce through 
its endotoxin the release Of TNF-a by maternal andlor fetal mononuclear cells. The 
maternal and fetal metabolic changes observed after injection of B./ragilis endotoxin in 
pregnant guinea pigs may also occur in case of subclinical intrauterine infection with 
Bacteroides /ragilis in pregnant women and, together with the known impact of TNF-a 
on DNA biosynthesis, could lead to fetal growth retardation. A tentative scheme of 
mechanisms leading to fetal growth retardation by B.fragilis endotoxin is presented in 
the figure. 
POSSIBLE MECHANISMS 
LEADING TO FETAL GROWTH RETARDATION 
AFTER INFECTION OF THE PREGNANT MOTHER 
WITH BACTEROIDES FRAGILIS 
LPS 
1 
o 
'fNF-a --------J anemia 
/J~ 
disturbed impaired disturbed 
carbohydrate meta.bollsm rat metabolism 
(hypoglycemia) (h'lpertriglyceridemia) 
relnl growlh I·elard.llon 
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Results of clinical and epidemiologic research performed during the last two 
decades suggest a link between subclinical infections of the pregnant woman and an 
unfavorable pregnancy outcome manifested in preterm labor and low birth weight. Low 
birth weight due to pretenn delivery or fetal growth retardation constitutes a major 
perinatal problem that contributes significantly to neonatal mortality and morbidity. 
Progress in the development of new rational approaches to prevention and treatment can 
only be achieved by further research to unravel the complicated pathophysiologic 
relationship between subclinical decidual-amniochorionic bacterial infection, the 
maternal and fetal immune system, the release of bioactive mediators, and maternal-
fetal responses. The studies presented in this thesis were designed to make a small 
contribution to this goa\. 
71 
72 
SUMMARY 
The studies presented in this thesis deal with the effects of Bac/eroides jragilis 
endotoxin on the maternal and fetal organism, in particular on fetal growth, with the 
pregnant guinea pig as the experimental animal. 
CHAPTER ONE is a general introduction to the thesis. The available literature on the 
influence of clinically manifest Of subclinical gram-negative aerobic and anaerobic 
decidual-amniochorionic infections on course and outcome of pregnancy is briefly 
reviewed. Release of inflammatory mediators and immunoregulatory cytokines induced 
by endotoxic Iipopolysaccharides could be involved in many of the pathophysiologic 
mechanisms leading to fetal growth retardation, but the evidence is limited and 
fragmentaL For that reason the questions addressed in the thesis concern the immune 
response to B./ragilis endotoxin in the pregnant guinea pig and the fetus, and the effects 
on maternal and fetal metabolism and fetal growth in relation to the biological activity 
of endotoxic lipopolysaccharide and cytokine release. 
CHAPTER TWO deals with the antibody response in mother and fetus after 
intramuscular administration of B.fragilis endotoxin. Comparison with nonpregnant 
guinea pigs showed that the humoral immune responsiveness to B./ragilis endotoxin, 
measured by IgM - and IgG levelS, was unsuppressed by pregnancy. At the end of 
gestation IgM and IgG antibodies against B..fragilis endotoxin were present in maternal 
and fetal sera and amniotic fluid. The detection of B..fragilis endotoxin in amniotic 
fluid, described in chapter 7, suggests that the fetal immune system might be stimulated 
by antigenic components of B.jragilis endotoxin transferred to the fetal compartment. 
Intramuscular administration of the endotoxin during the second half of gestation was 
associated with a reduction in fetal weight. 
CHAPTER THREE presents an experimental study to explore the intluence of B.jragilis 
endotoxin on the development of maternal and fetal weight. Repeated intramuscular 
administration of the endotoxin during the second half of pregnancy significantly 
reduced maternal weight gain and fetal weight. The observation of an unaffected 
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placental weight but a significantly reduced fetal liver mass points towards an effect of 
B.fragilis endotoxin on maternal and fetal metabolism. 
CHAPTER FOUR describes experiments designed to investigate the influence of 
B.fragilis endotoxin on maternal prostacyclin synthesis and maternal and fetal 
carbohydrate and fat metabolism. The endotoxin challenge resulted in increased 
maternal serum levels of prostaglandin FI " fetal hypoglycemia and maternal and fetal 
hypertriglyceridemia. 
CHAPTER FIVE presents a study on the release of tumor necrosis factor a (TNF-a) 
after intramuscular injection of B.fragi/is endotoxin into the pregnant guinea pig. It was 
shown that B.Jragilis endotoxin induces the release of TNF-a, followed by a slight 
transient hyperglycemia. a significantly reduced hematocrit and a significantly increased 
concentration of prostaglandin Flo in maternal serum. In vitro experiments confirmed 
the capacity of B.Jragilis endotoxin to induce TNF-a release in human and guinea pig 
macrophages. 
CHAPTER SIX describes results of a study designed to explore structural features of 
the endotoxin which are involved in the expression of biological activity. In earlier 
investigations 2-keto-3-deoxyoctonate (KDO), an 'inner core' constituent of entero and 
non-enterobacterial Jipopolysaccharides participating in the stimulation of cytokine 
release by activated macrophages, was claimed to be absent in Bacteroides 
Iipopolysaccharides. In contrast to these earlier observations, the presence of KDO in 
endotoxins isolated from six different strains of the B.fragilis group was detected after 
dephosphorylation of the endotoxins with 50 % hydrofluoric acid. Phosphorylation of 
this essential structural component of endotoxins may contribute to the, in comparison 
with the E.coli or Salmollella species less severe, but still effective, impact of B.ft'agilis 
endotoxin on fetal growth and metabolism. 
CHAPTER SEVEN deals with experiments designed to assess the possible transfer of 
maternal endotoxin into the fetal compartment. B.jragilis endotoxin was detected by 
single radial immunodiffusion and counterimmunoeiectrophoresis in concentrated 
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amniotic fluid of guinea pigs after repeated intramuscular injection of the endotoxic 
lipopolysaccharide during the second half of gestation. A few (physico)chemical 
characteristics of the endotoxin used for all studies included in this thesis are described. 
The purified lipopolysaccharide was antigenically still heterogenous, with a molecular 
weight of the smallest fraction between 10000 and 5000 D. All serologically reactive 
components were carbohydrates, protein components were not observed. 
CHAPTER EIGHT presents a general discussion of the results of the studies described 
in this thesis. The results support the hypothesis that E./ragilis, when present in the 
uterine tissues of the pregnant woman, may induce through its endotoxin the release of 
TNF·" by macrophages, which could be responsible for pathophysiologic changes in the 
maternal and fetal carbohydrate and fat metabolism. Together with the known impact of 
TNF·" on DNA biosynthesis these effects could lead to fetal growth retardation. 
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SAMENVATIING 
In dit proefschrift wordt dierexperimenteei onderzoek beschreven bij de 
drachlige cavia naar de effeclen van hel endoloxine van Bacteroides jragilis op hel 
moederlijke en foelale organisme, in hel bijzonder op de groei van de foetus. 
HOOFDSTUK EEN geeft een algemene inleiding. In hel karl wordl de beschikbare 
literaluur besproken mel belrekking lot de invloed van klinisch manifesle of subklinische 
gram-negatieve aerobe en anaerobe infecties van de decidua en het amniochorion op het 
verloop en de uitkol11st van de zwangerschap. Endotoxine Jipopolysacchariden indliceren 
het vrijkomen van ontstekingsmediatoren en cytokines, die betrokken zouden kunnen 
zijn bij veel van de pathofysiologische mechanismen die lei den 101 foetale 
groeivertraging. De wetenschappelijke basis voor deze hypolhese is echter beperkl en 
fragmcntarisch. Daarom wordt in dit proefschrift getracht cen aantal vragen Ie 
beantwoorden met betrekking tot de immuunrespons van de drachtige cavia en haar 
foelus op endotoxine van B.fragilis en de effeclen op hel moederlijke en foelale 
mctabolisme en de foetale groei in sam en hang met de biologische activiteit van 
endotoxine lipopolysacchariden en daardoor geinduceerde cytokines. 
HOOFDSTUK TWEE geeft een beschrijving van experimenlen met betrekking tot de 
antilichaam-reactie in moeder en foetus na intramuscuiaire toediening van het 
endotoxine van B.fragilis. In vergelijking met de niet-drachtige cavia wordt de hUlllorale 
irnmuunreactie op B . .fi°agilis endotoxine, gemeten aan de hand van IgM en IgG 
concentralies, niel onderdrukl door de zwangerschap. Aan het einde van de 
zwangerschap waren IgM en IgG antilichamen tegen B.fragilis endotoxine aanwezig in 
het ll10ederlijke en foetale serum en in vruchtwater. De bevinding dat B.frugilis 
endotoxine kan worden aangetoond in vruchtwater, loals beschreven in hoofdstuk 7, 
wijst erop dat het foetale immuunsysteem lOU kunnen worden gestimuleerd door 
antigene componenten van het endotoxine, die zijn overgegaan naar het foetate 
compartiment. De intral11l1sculaire toediening van endotoxine in de tweede heW van de 
drachl ging samen mel een duidelijk verlaagd foelaal gewicht. 
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HOOFDSTUK DRIE beschrijft een experimenteel onderzoek naar de invloed van het 
endotoxine van B.fragilis op de ontwikkeling van het moederlijke en foetale gewicht. 
Herhaalde intramusculaire toediening van endotoxine tijdens de tweede helft van de 
zwangerschap leidde tot een significante vermindering van de moederlijke 
gewichtstoeneming en van het foetale ge\Vicht. Het gewicht van de placenta werd door 
toediening van endotoxine niet bei'nvloed, maar het gewicht van de faetale lever was 
significant lager dan in de controlegroep. Dit \Vijst op een effect van het endotoxine van 
B.ji·agilis op de moederlijke en de foetale stofwisseling. 
HOOFDSTUK VIER geeft een verslag van experimenten gericht op het onderzoeken 
van de invloed van endotoxine van B./i'{Jgi/i,v op de moederlijke synthese van 
prostacyclinc en ap het moederlijke en foetale metabo!ismc van koolhydraten en vettcn. 
Toediening van endotoxine aan de drachtige cavia leidde tot cen toeneming van de 
concentratie van prostaglandine F to in moederlijk serum, foetale hypoglykemie, en 
moederlijke en foetale hypertriglyceridemie. 
HOOFDSTUK VUF beschrijft een onderzoek naar de vonning van tumor necrosis 
factor-a (TNF-a) na intramusculaire toedicning van het endotoxine van B.fragilis aan de 
drachtige cavia. Toediening van B.fragilis endotoxine induceert de afgifte van TNF-a, 
gevolgd door een voorbijgaande moederlijke hyperglykemie, een significant verlaagde 
hematocrietwaarde en cen significant toegenomen concentratie van prostaglandine FlO: in 
moederlijk serum. Door middel van experimenten in vitro werd bevestigd dat het 
endotoxine van B.jhlRilis in staat is om de vorming van TNF-a door macrofagen van de 
mens en de cavia te stimuleren. 
HOOFDSTUK ZES geeft de resultaten van een onderzoek naar structurele 
eigenschappen van endotoxine die betrokken zijn bij de expressie van de biologische 
activiteit. Resultaten van eerdere onderzoeken lOuden erop \Vijzen, dat 2-keto-3-
deoxyoctonate (KDO), een onderdeel van de tlinner core" van entero- en niet-
enterobacteriele Iipopolysacchariden dat van belang is voor het stimuleren van de afgifte 
van cytokines door geactiveerde macrofagen, afwezig was in het lipopolysaccharide van 
Bacteroides. In tegenstelling tot de resultaten van die onderzoeken werd de 
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aanwezigheid van KDO aangetoond in endotoxinen ge'isoleerd uit zes verschillende 
stammen van de B.Fagilis groep, na defosforilering met 50% hydrofluorzuur. 
Fosforilering van deze essentieie strllcturele component van endotoxinen draagt 
waarschijnlijk bij aan het, in vergelijking met E.coU of Salmonella, geringere effect van 
het endotoxine van B.Fagilis op de groei en het metabolisme van de foetus. 
HOOFDSTUK ZEVEN beschrijft experimenteel onderzoek naar de transplacentaire 
overgang van aan de moeder toegediend endotoxine naar de foetus. Het endotoxine van 
B.Fagilis werd aangetoond door mid del van enkelvoudige radiale immunodiffusie en 
counterimmunoelectroforese in geconcentreerd vruchtwater van drachtige cavia's na 
herhaalde intramusculaire toediening van het endotoxine lipopolysaccharide tijdens de 
tweede helft van de dracht. Tevens wordt een aantal (fysisch-)chemische eigenschappen 
beschreven van het endotoxine dat werd gebruikt voor aile experimenten beschreven in 
dit proefschrift. Het gezuiverde lipopolysaccharide was in antigeen opzicht heterogeen, 
met een moleculair gewicht van de kleinste fractie tussen 10.000 en 5.000 D. Aile 
serologisch reactieve componenten waren koolhydraten, eiwitbestanddelen werden Iliet 
aangetoond. 
HOOFDSTUK ACHT geef! een algemene bespreking van de resu!taten van de 
onderzoeken, die worden beschreven in dit proefschrift. De resultaten steunen de 
hypothese dat het endotoxine van B./ragilis, indien aanwezig in de uterus van de 
zwangere vrouw, macrofagen kan induceren tot afgifte van TNF-a, dat verantwoordelijk 
kan zijn voor pathofysiologische veranderingen van het moederlijke en foetale 
metabolisme van koolhydraten en vetten. Samen met het bekende effect van TNF-a op 
de biosynthese van DNA kan dit leiden tot foetale groeivertraging. 
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